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Abbreviations 
30A  name of a polar test point arrangement within 30° of eccentricity 
84NO  name of a polar test point arrangement within 84° of eccentricity 
AIDS  acquired immune deficiency syndrome 
AION  anterior ischemic optic neuropathy 
cLoA  corrected limits of agreement 
CMOS complementary metal oxide silicon 
CRP  C-reactive protein 
dB  decibel 
dBs  standardized decibel scale 
DLS  differential luminance sensitivity 
dpt  dioptre 
ESR  erythrocyte sedimentation rate 
EyeSuite EyeSuite Perimetry, a perimetry software offered by the Haag- 
  Streit company, Köniz, Switzerland 
FT  full threshold 
GATE  German adaptive thresholding estimation 
GATEe commercially available GATE strategy as integrated in EyeSuite  
  Perimetry 
GATEe1075 examination on serial device 1075, max. stimulus ≈ 3183 cd/m²  
  (10,000 asb), using GATEe 
GATEe894 examination on serial device 894, max. stimulus ≈ 1273 cd/m²    
  (4000 asb), using GATEe 
GATE-i German adaptive thresholding estimation – initial examination 
GATEp the prototype version of the GATE strategy as developed in  
  Tuebingen 
HIV  human immunodeficiency virus 
ICC  intraclass correlation coefficient  
IOP  intraocular pressure 
LOA  limits of agreement 
MD  mean defect 
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MS  mean sensitivity 
NAION non-arteritic anterior ischemic optic neuropathy 
NQA   number of questions asked 
RAPD  relative afferent pupil defect  
RNFL  retinal nerve fibre layer 
RP   retinitis pigmentosa 
SITA  Swedish interactive thresholding algorithm 
TL  test location 
VF  visual field 
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1. Introduction 
1.1 Preliminary remarks on perimetry 
1.1.1 The visual field 
The monocular visual field refers to the sum total of visual perception for an eye 
fixed on a stationary object of regard with the head and body held fixed in 
position. [1] 
Under photopic conditions, the site with the highest concentration of cones 
within the retina is called the fovea. This is the site with the highest sensitivity of 
the visual field. The peripheral visual field extends to approximately 100° on the 
temporal side, to approximately 70° on the inferior side and to approximately 
50° on the superior and the nasal side. [1] Sensitivity decreases with the 
declining concentration of cones towards the periphery. Thus, in a 3-
dimensional illustration a visual field can be depicted as an “island of vision” 
with a central peak - the fovea - that is sinking with locally varying steepness 
towards the periphery into the “sea of blindness”. [2] 
 
Areas of lower sensitivity than expected – i.e. visual field defects - are called 
scotomas. These defects are referred to as relative or absolute scotomas 
depending on how profound the visual loss is. If there is no more perception, 
even if the stimulus is presented with maximum luminance or if the local 
differential luminance sensitivity (DLS) level is reduced by more than 20 dB 
compared to the age-related normal DLS level, this defect is called an absolute 
scotoma; like for example the blind spot. In case of a relative scotoma there can 
still be perception, but the stimulus has to be presented with a higher luminance 
level than the local age-adjusted normal value. 
 
Visual fields are always dependent on a functioning of all elements of the visual 
pathway, starting even with the refractive media, followed by the retinal 
photoreceptors and ending with the neuronal elements of the visual cortex. By 
this, they are representing the afferent functions of the visual system. It is 
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therefore possible to draw conclusions from special patterns of visual field 
defects in order to predict where the topographic location of the damage to the 
visual pathway is supposed to be. In addition, the assessment of local DLS 
values allows for analysis of change (deterioration or improvement over time). 
 
The current gold standard for the assessment of overall visual function in 
clinical practice and in research environment is visual acuity testing and 
perimetry.  
1.1.2 Perimetry 
Perimetry is the psychophysical examination and measurement of visual 
function at defined topographic locations of the visual field. It is a non-invasive 
examination providing topo-diagnostic and etiological pathogenic information 
about the visual field of the examined subject. Stimuli are presented in a dome-
shaped projection area and have to be recognized and confirmed by the 
proband. Test points may vary in size, luminance and location, but the 
background luminance is kept constant throughout the examination in order to 
provide a constant state of adaption 
 
Perimetry measures differential luminance sensitivities. The logarithmic 
measurement unit is decibel (dB). The DLS is defined as the threshold of 
perception of a test point in relation to the background luminance of the 
perimeter. This indicates a quantification of the contrast perception capability. A 
threshold is given if the probability of perception is 50% at a given location of 
the visual field according to the psychometric function. 
 
The psychometric function – also known as the probability-of-seeing-curve -
describes the probability of response (in %) dependent on the level of stimulus 
attenuation (in dB). The steeper the curve at the point of change from 
unequivocal perception to no perception, the smaller is the statistical variance 
for repeated measurements. This has immediate implications for test-retest 
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variability. In other cases the curve shows a shallower course with greater 
statistical variance representing greater test-retest variability in these places. 
 
This explains one of the major disadvantages of perimetry: its often high test-
retest variability.  In addition, low reproducibility results in a reduced sensitivity 
for changes over time. [3] Furthermore, as in any psychophysical test 
procedure, perimetry bears the risk of fatigue effect; also a learning effect may 
be observed. [4]  
 
In spite of this, perimetry has a great impact on the evaluation of special eye 
diseases and their treatment, especially in glaucoma diagnostics and 
surveillance.  
 
Further indications for a perimetric examination are an impaired vision of 
unknown origin, a relative afferent pupil defect (RAPD), clarification and 
surveillance of suspected visual pathway lesions and the need of an expert 
opinion and formal certification of seeing capability. The main purpose of 
perimetry, however, is the detection and surveillance of scotomas. [5] 
 
There are two basic principles of perimetry: kinetic and static perimetry.  
1.1.2.1 Kinetic isopter perimetry 
In kinetic perimetry test points that are constant in size and intensity are 
introduced by movement. By this, the borders between fields of normal vision 
and scotomas are examined. Since it is a very interactive method, results are 
highly dependent on the examiner, but offer a high efficiency and flexibility.  
In order to achieve reproducible results, it is helpful to follow some rules for all 
examinations: Movement should be introduced from the non-seeing into the 
seeing part of the visual field with a constant angular velocity (approximately 2-
5°/s). Three to four passes, each with different stimulus brightness and/or 
stimulus size should be executed. [6] By that, the examination delivers lines 
displaying the same DLS, the so-called isopters, which are similar to contour 
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lines of topographic maps. Manual or semi-automated examinations may be 
executed. The latter offers a higher degree of independency from the examiner 
at the cost of reduced flexibility. 
Kinetic perimetry is a good tool for the characterization of advanced visual field 
loss and is of high relevance for the evaluation of limitations of vision in patients’ 
everyday life and for expert opinion. [5] 
1.1.2.2 Static automated grid perimetry (used in this study)  
In static automated grid perimetry stationary stimuli are presented in random 
order at varying intensity levels at different test locations that are arranged in a 
defined grid pattern. The depth of a defect can be evaluated by comparing the 
achieved DLS to the age-corrected normative values of the hill of vision. 
 
Automated static visual field examinations have some major advantages 
compared to manual or semi-automated static perimetry. The most obvious 
advantage is the automated process of stimulus presentation allowing for 
randomization and increasing the reproducibility of examination. Different grids 
and strategies may be applied depending on the patient’s ocular pathology and 
capability to perform the perimetric examination. In more recent perimeters 
infrared cameras allow the supervision of fixation, position and even vigilance of 
the test subject throughout the whole examination. In spite of all these great 
advantages, perimetry has stayed a long and tiring task with excessive 
demands of the patient making it a rather unpopular examination for patients 
[7]. Results are highly dependent on vigilance, cooperation, motivation and 
understanding of the patient and even though the examination itself is 
automated, technician experience still has a significant influence on the mean 
defect (MD). [8–10] With shorter test durations the strain of performing 
perimetry should be eased with helpful effects on fatigue, vigilance, cooperation 
and motivation. Static automated grid perimetry is a very important tool for 
glaucoma diagnostics and trend surveillance. [11]  
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1.1.2.3 Test point arrangements (grids) 
By using automatic perimeters with a mirror-projection system for stimulus 
projection, almost every location of the visual field can potentially be tested 
technically. But since it is not possible to test every perceptive point of the retina 
for practical reasons, test points and their arrangement have to be chosen 
wisely depending on the goal of the perimetric examination. Rectangular grids 
with an equidistant test point arrangement offer the advantage to detect defects 
within mathematically well-defined Cartesian coordinates. [11] These grids are 
easy to manage and used widely. However, they do not realistically represent 
the arrangement of photoreceptors, which are arranged in a circular order 
around the center and increase in density towards the foveola.  
In this study a concentric test point arrangement that respects the horizontal 
and vertical meridian was applied. By that, the actual arrangement of cones in 
the retina is represented more adequately. This is especially important, because 
conventional perimetry examines under photopic conditions (10 cd/m²), thereby 
exclusively addressing the cone system. Two different concentric grids were 
used in this study, one restricted to the central 30° (grid 30A) and one covering 
the whole almost 90° of the visual field (grid 84NO). Concentric grids often 
implement an increase of stimulus density towards the visual field center. [5]  
1.1.2.4 Strategies for automated static perimetry 
Suprathreshold tests 
Suprathreshold tests offer an efficient and easy-to-perform evaluation of visual 
field status. They are based on the principle that the initial stimulus intensities 
are set a little above the expected threshold level. Test points are classified into 
three defect levels: normal, absolute and relative defect. However, the local 
DLS values are not assessed quantitatively. Therefore, suprathreshold tests are 
a good tool for screening examinations, for comparatively high spatial resolution 
and are useful especially for subjects that are inexperienced or incapable of 
performing other perimetric strategies. However, due to the lack of quantitative 
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local DLS values they are of minor importance for perimetric follow-up of 
chronic diseases (e.g. glaucoma). 
Threshold tests 
Threshold tests estimate the sensitivity at each test location. For good 
interpretability they need an adequate spatial resolution of the test point 
arrangements. Threshold tests allow follow-up testing to detect change in an 
early stage. So, they are the preferred strategy for surveillance of chronic eye 
diseases affecting the visual field. [9,12] The local DLS values are usually 
estimated on the basis of a staircase algorithm.  
Full threshold (FT) 
The gold standard of threshold testing is the Full Threshold strategy with a 4-2-
1-dB staircase algorithm which needs three reversals of responses to terminate 
the examination at a given location.[13] Threshold tests have longer 
examination durations than screening tests, but they offer quantitative 
information. [14] 
 
In order to shorten the examination duration of threshold testing several 
algorithms have been developed: 
FASTPAC 
This strategy saves about 40% of test time by accepting less accurate 
estimates of threshold. It uses 3-dB steps instead of 4-2-dB steps and stops 
testing already after one single response-reversal. This leads to higher short-
term fluctuation, which makes it less accurate and reliable in surveillance and 
following of defects. [15,16] 
TOP (Tendency-oriented Perimetry) 
TOP is an ultra-short automated perimetry test, which only tests each stimulus 
once at each test location and calculates the threshold estimate by taking into 
account information from adjacent points. By this, it is up to four times faster 
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than a standard thresholding technique while producing similar results with a 
good diagnostic ability. TOP, however, tends to soften edges of sharp scotoma 
and makes them seem shallower and smaller. This may lead to an 
underestimation of visual field loss. [17–19] 
SITA (Swedish Interactive Threshold Algorithm) 
When introduced in 1998, [20] this method was extraordinary, because it was 
able to approximately halve test time by several different ways: Staircase 
starting values are calculated by visual field modeling, Bayesian posterior 
probability functions and frequency-of-seeing-curves taking into account 
surrounding test locations. The 4-2-dB staircase procedure is interrupted at a 
predetermined level of uncertainty. Furthermore, test pacing allowing adaptation 
of stimulus presentation time to the patient’s reaction time and a method of 
calculating catch trials instead of testing them [21] lead to further test time 
reduction. Like for FT, test times increase with growing visual field defects. [22] 
There are two types of SITA: SITA Standard uses double crossing of threshold 
with a 4-2-dB-staircase, analogous to the Full Threshold method. SITA Fast, 
however, uses a 3-dB-staircase with single crossing like FASTPAC. When SITA 
was validated for normal and glaucomatous eyes [20,23], sensitivities were 
observed  that were 1-2 dB higher than for conventional testing. [23,24]  
Disadvantages of SITA are the restriction to rectangular grids within 30° 
eccentricity and its deficient consideration of previous examinations. 
Furthermore, it has been released for manifest glaucomatous visual field defect 
only and not all details of the post-processing algorithm have been published. 
The dynamic strategy by Weber 
This strategy uses step sizes varying between 2 and 10 dB depending on the 
sensitivity according to physiological data. It showed to be more efficient than a 
strategy with fixed step sizes. [25] It is not as fast as TOP [26] and has shown a 
higher short-term fluctuation than the standard Octopus program [27]. 
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CLIP (Continuous light increment perimetry) 
By using a modified ramp stimulus with continuously increasing intensity this 
strategy enhances patient compliance (also in children [28]). The stimulus 
presentation starts with a subthreshold intensity and stops when recognized by 
the proband. CLIP saves approximately 38% of test time compared to FT. [29] 
However, local adaptation varies due to differing presentation durations for each 
test location. 
 
In 2009 another new fast-thresholding algorithm was launched based on a 
modified 4-2-dB staircase strategy for automated static perimetry: GATE. This 
method does not only incorporate population information, but also benefits by 
including information from previous tests. [30] 
1.2 GATE (German Adaptive Thresholding Estimation) strategy 
For a faster completion of threshold-estimating static visual field examinations a 
new fast-thresholding algorithm was developed by U. Schiefer and J. Paetzold, 
university eye clinic Tuebingen, and called “German Adaptive Thresholding 
Estimation (GATE)”. When compared to the full threshold strategy (FT) and 
SITA Standard in a multicentre study it achieved comparable results. Accuracy 
and test-retest reliability have shown to be similar to both other strategies, but 
GATE showed a much shorter test duration than FT. [13] GATE is able to 
determine accurate thresholds over the entire sensitivity range and is applicable 
to all kinds of ophthalmologic pathologies and any test point arrangement. 
 
The algorithm consists of “GATE-i” which is used for the initial examination of a 
patient and “GATE” which is used for all subsequent examinations. GATE-i 
begins with the testing of 5 predefined seed points. The achieved DLS values 
are then compared to the age-corrected normal hill of vision. If necessary, 
deviations of the seed locations from the normative values are taken to adapt 
the other starting stimulus intensities.  
A modified 4-2-dB staircase strategy follows the testing of the seed points. Two 
reversals are needed in order to terminate the examination of a test point. A 
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local threshold is defined as the value between the brightest stimulus not seen 
and the dimmest stimulus seen. Precocious termination is possible in areas of 
deep or absolute defect: If the initial stimulus, that is slightly higher than the 
suspected DLS, is not answered within a given time window, a stimulus of 
maximum brightness is presented. If this stimulus is also not answered, the 
testing at that location is terminated. 
The GATE algorithm differs only by the fact that the starting values are not 
based on adjusted age-related normative values, but on previously accessed 
local thresholds of precedent examinations. By that, GATE needs even shorter 
examination times than GATE-i.  
Thus, GATE is an algorithm that examines visual fields in an adaptive method 
(adaption of initial stimulus intensities to the age-corrected normative values for 
GATE-i and adaption of initial stimulus intensities to precedent examinations for 
GATE) in order to perform threshold estimating perimetry.  
1.3 Purpose of this study 
Until now GATE has only been available in a prototype version for laboratory 
use (GATEp). In order to be able to introduce this fast-thresholding algorithm 
into clinical practice, the license rights have been sold to Haag-Streit AG, Köniz, 
Switzerland, that integrated the algorithm into their commercially available 
EyeSuite Perimetry software (GATEe). 
 
The primary objective of this study was to assess the agreement between this 
incorporated (GATEe) and the original version (GATEp) of the algorithm 
regarding local differential luminance sensitivity (DLS). The results were to be 
related to and evaluated by the also assessed repeatability of GATEp. 
Furthermore, the examinations were also performed by a perimeter of the 
newest generation (serial device 1075) with LED background illumination and a 
higher maximum stimulus luminance using the GATEe algorithm. Possible 
effects of the different illumination on the measurement results were assessed. 
GATEe was therefore performed on two different perimeters: serial device 104 
with a maximum stimulus luminance of 1273 cd/m² (4000 asb), i.e. GATEe104, 
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and serial device 1075 with a maximum stimulus luminance of 3183 cd/m² 
(10,000 asb), i.e. GATEe1075. 
Secondary objectives were the comparison of examination durations and mean 
sensitivity (MS). 
2. Subjects and methods 
2.1 Subjects 
Since examinations of the visual field are notably relevant for particular eye 
diseases concerning prognosis, therapy and monitoring of the disease, four 
groups of patients representing four different diseases affecting the visual field 
have been examined. These groups were as follows:  
1) 15 patients suffering from manifest glaucoma  
2) 3 patients with NAION (Non-Arteritic Anterior Ischemic Optic Neuropathy)  
3) 6 patients with chiasmal or postchiasmal lesions of the visual pathway 
resulting in a homonymous hemianopia or quadrantanopia  
4) 6 patients suffering from tapeto-retinal degeneration (Retinitis 
pigmentosa (RP)) 
 
In total, 30 patients were examined, 17 men and 13 women between 22 and 78 
years of age (mean: 58.7 years). All patients underwent eight perimetric 
examinations. Therefore, 240 examinations were completed altogether.  
13 right eyes and 17 left eyes were chosen as study eyes according to the 
inclusion criteria of the different groups of diseases that will be explained in the 
following. 
See Table 1 for an overview of all recruited test subjects. 
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Table 1: Recruited test subjects 
((post-) chiasmal = (post-) chiasmal pathway lesions) 
RP = Retinitis pigmentosa, OS = left eye, OD = right eye) 
Patient ID Gender Age [years] Disease Eye 
2201 Male 73 NAION OD 
2202 Female 53 Glaucoma OD 
2203 Female 76 Glaucoma OS 
2204 Female 61 Glaucoma OS 
2205 Female 66 Glaucoma OS 
2206 Female 71 Glaucoma OS 
2207 Male 62 Glaucoma OS 
2208 Male 65 Glaucoma OS 
2209 Male 65 Glaucoma OD 
2210 Female 78 NAION OS 
2211 Male 53 Glaucoma OS 
2212 Female 75 Glaucoma OS 
2213 Male 41 (post-) chiasmal OD 
2214 Male 76 NAION OS 
2215 Male 66 Glaucoma OD 
2216 Male 72 (post-) chiasmal OD 
2217 Male 56 Glaucoma OD 
2218 Female 64 (post-) chiasmal OS 
2219 Male 22 RP OS 
2220 Male 55 (post-) chiasmal OD 
2221 Female 38 (post-) chiasmal OS 
2222 Male 65 RP OD 
2223 Male 59 Glaucoma OD 
2224 Female 62 Glaucoma OS 
2225 Male 61 RP OS 
2226 Male 44 RP OS 
2227 Female 67 RP OD 
2228 Female 29 RP OD 
2229 Male 60 Glaucoma OD 
2230 Female 27 (post-) chiasmal OS 
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2.1.1 Groups of subjects 
2.1.1.1 Glaucoma 
Glaucoma is the umbrella term for a number of different ophthalmologic 
diseases of different aetiology resulting in an optic neuropathy with 
characteristic morphological changes of the optic disc and typical visual field 
defect patterns, often accompanied by a high intraocular pressure (IOP). There 
is no healing therapy for glaucoma, but if left untreated, it may result in 
blindness of the eye. [31] Diagnostic criteria include: structural damage of the 
optic nerve head resulting in increasing excavation (which may be detected by 
measuring the vertical disc-cup-ratio) and/or focal notching with accompanying 
local atrophy and functional damage, i.e. visual field defects resulting in 
characteristic nerve fibre bundle defects. [32] 
Most of the perimetric examinations in outpatient care are applied to glaucoma 
patients. Besides other examinations like ophthalmoscopy, morphometry (e.g. 
optical coherence tomography = OCT) of the retina and tonometry, perimetry is 
important for glaucoma patients in order to diagnose the disease and for follow-
up purposes. Perimetry can help to differentiate, if the patient suffers from a 
slowly progressive functional loss or a more aggressive form of the disease, 
which would have an impact on the aggressiveness of treatment. [33] In 
glaucoma patients threshold estimating static perimetry of the 30° central visual 
field is recommended. [34] The most important treatments of glaucoma are 
medical and surgical methods to reduce the IOP depending on the aetiology in 
order to prevent progression of visual field defects. 
Patients were included into the study, if the optic nerve head and/or retinal 
nerve fibre layer (RNFL) and visual field were abnormal, according to the 
classification stages I-III (AULHORN classification [35]). The affected eye was 
chosen as study eye. If both eyes were affected, the worse eye was chosen. 
2.1.1.2 AION 
The anterior ischemic optic neuropathy (AION) is an acute ischemia of the 
papilla because of vessel transformation of either inflammatory (arteritic AION) 
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or arteriosclerotic reasons or because of a hypotonic situation (non-arteritic 
AION). Patients complain of sudden vision impairment or even blindness in one 
eye. Altitudinal visual field defects, especially of the lower half, are typical. The 
extent of the defects depends on the degree of destruction of the papilla and the 
optic nerve. Typical signs in ophthalmoscopy are optic disc oedema and 
segmentally blurred disc margin, sometimes combined with hyperaemia and 
disc haemorrhages followed by segmental atrophy of the optic nerve head. [31] 
Improvement or further deterioration of visual field and visual acuity may mostly 
be observed up to 6 months after the ischemic event. Thereafter further 
significant change is very rare. [36] If the reason for the AION is inflammatory 
(giant cell arteritis), it is of utmost importance to treat with high-dose steroids as 
soon as possible in order to protect the fellow eye and prevent occlusion of 
brain vessels. Important diagnostic signs for giant-cell arteritis are a high 
erythrocyte sedimentation rate (ESR) and elevated C-reactive protein (CRP). 
Also, the patients often suffer from pathognomonic jaw claudication. [31] 
Follow-up of the visual field defects (under therapy) is the main purpose of 
perimetric examinations of AION patients. When performing static perimetry 
threshold-estimating strategies are useful, because of their ability to detect and 
quantify both local defects and diffuse reduction of sensitivity. [34] 
For this group the affected eye was chosen as the study eye. 
2.1.1.3 Chiasmal or postchiasmal lesions of the visual pathway 
Chiasmal lesions of the visual pathway normally result in heteronymous 
bitemporal visual field defects with a great variability depending on the aetiology 
and location of the lesion. In many cases the underlying pathology is a pituitary 
tumour or craniopharyngioma. Further reasons are other tumours, aneurysms 
or inflammatory processes. Neurosurgical and medical therapies are applied. 
Postchiasmal lesions are due to numerous neurologic diseases like tumours, 
vascular insults, basal meningitis, trauma, abscesses or aneurysms. They all 
result in contralesional homonymous visual field defects. The most important 
diagnostic tool in this case regarding topographic information is perimetry, since 
typical visual field defects occur depending on the location of damage along the 
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visual pathway (optic tract, lateral geniculate nucleus, optic radiation, visual 
cortex). Therapy and prognosis depend on the location and aetiology of the 
damage. Neurosurgery or neurologic treatments are possible, but regression of 
postchiasmal damage in visual field defects is rare. [31] 
Inclusion criteria for this group were homonymous or heteronymous hemianopia 
or quadrantanopia regardless of origin. Stroke was no exclusion criteria in this 
group. The study eye was chosen by randomization. 
2.1.1.4 Tapeto-retinal degeneration: Retinitis pigmentosa 
A heterogeneous group of retinal pathologies leading to nyctalopia and 
progressive loss of visual acuity and constriction of the visual field is called 
retinitis pigmentosa. In its classical form a concretion of retinal pigments is a 
typical symptom. This concretion proceeds from the mid-periphery towards the 
fovea. So, in the course of the disease the visual field narrows step by step. It 
usually starts with the destruction of the rods and later also the cones, which 
first leads to a disorder of colour and contrast vision and later even to optic 
atrophy. Since there is no curative or prophylactic therapy the disease is of a 
chronic progressive character and may lead to blindness. 
For retinal diseases perimetry is a tool which helps to discern differential 
diagnoses and helps in trend surveillance. There are often small remaining 
islands of vision in the periphery apart from the typical small concentric visual 
field, even though the disease is already quite advanced. This is why grid 84NO 
has been applied for retinitis pigmentosa patients in this study. Patients were 
included, if suffering from retinitis pigmentosa of the classical form in different 
stages of the disease. The study eye was chosen by randomization. 
2.1.2 Inclusion criteria 
 Physical, intellectual and linguistic abilities in order to understand the test 
requirements 
 Willingness to comply with the protocol of the 2 visits 
 18 years old, informed consent 
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For the study eye: 
 Spherical ametropia max. ± 8 dpt, cylindrical ametropia max. ± 3 dpt 
 Distant visual acuity better than 10/20 
 Isocoria 
 Pupil diameter > 3mm 
2.1.3 Exclusion criteria 
 Pregnancy, nursing 
 Diabetic retinopathy 
 Asthma 
 HIV positive or AIDS 
 History of epilepsy or significant psychiatric disease (e.g. dementia) 
 History of stroke (except for patients in the group of visual pathway lesions) 
 Medications known to affect the visual field sensitivity 
 Acute ocular infections (e.g. keratitis, conjunctivitis, uveitis) 
 Severely dry eyes 
 Miotic drugs 
 Amblyopia 
 Squint 
 Nystagmus 
 Albinism 
 Any ocular pathology in either eye that may interfere with the ability to obtain 
visual fields, disc imaging or accurate IOP readings 
 Keratoconus 
 Intraocular surgery (except for uncomplicated cataract or glaucoma surgery 
performed >3 months prior to screening) 
 History or presence of macular disease and/or macular oedema 
 Relevant opacities of central refractive media (cornea, lens, vitreous body) 
 Ocular trauma 
 Suspected lack of compliance 
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In this study, patients with false-negative or false-positive rates exceeding 30% 
were not excluded from the analysis, because of the assumption, that false-
negative answers are often increased in patients with severe visual field loss 
and in order to draw conclusions from a very realistic sample of visual field 
examinations as would be normal for everyday ophthalmologic practice. 
These patients all suffered from severe visual field loss, either because of 
advanced glaucomatous loss (patient IDs 2205, 2211, 2212, 2217, 2223) or 
from homonymous hemianopia (patient ID 2216).  
See Table 16: Elevated catch trial rates (Appendix) 
2.1.4 Recruiting of subjects 
Recruiting of participants for the study was accomplished via two different ways: 
Firstly, patients from the outpatient clinics of the university eye hospital in 
Tuebingen, e.g. the outpatient glaucoma service, were screened individually by 
the investigator. Secondly, patients meeting all inclusion criteria were contacted 
via telephone call and asked to participate in the study. Inclusion and exclusion 
criteria were checked by the information given in the AIS (information system for 
doctors of the university eye hospital Tuebingen) and by the patients’ history.  
2.2 Study design 
Two visits within 14 days have been scheduled for each of the chosen 30 test 
subjects. At their first visit the patients received all relevant information about 
the purpose and the exact procedure of the tests. They all signed an informed 
consent. Afterwards, four examinations using the GATE-i strategy were 
performed. In glaucoma patients the IOP was measured with a non-contact 
tonometer. The first visit took approximately 1.5 hours. At the second visit four 
examinations were performed using the GATE-strategy, which took 
approximately one hour. 
The four static visual field examinations at each visit were performed with three 
different Octopus 900 devices:  
GATEp1 prototype GATE software, serial device 104, first examination 
GATEp2 prototype GATE software, serial device 104, second examination 
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GATEe894 EyeSuite GATE software, serial device 894 
GATEe1075 EyeSuite GATE software, serial device 1075, a perimeter of the  
  newest generation with LED background illumination and higher  
  maximum stimulus luminance (3183 cd/m² = 10,000 asb) 
 
The order of the four examinations was randomized in advance for each test 
subject and each visit. The patients were free to choose their breaks individually 
between the examinations, but at least one break had to be taken. All 
examinations were monitored continuously by the investigator. 
 
Prior to the recruitment of participants and the first examination, the study had 
been reviewed by the independent Ethics Committee of the faculty of medicine, 
Tuebingen University, and was approved to comply with the tenets of the 
Declaration of Helsinki. It was also registered at ClinicalTrials.gov. The clinical 
trial number was NCT01265628. 
This was a non-invasive study, no medication was tested and there was no 
known additional risk due to the diagnostic equipment. The devices were 
commonly used in diagnostic procedures. Regular safety tests were done by 
"Medizintechnisches Servicezentrum des Universitätsklinikums Tuebingen". 
The participants received 32 € expense allowance per visit and were granted an 
accident en route insurance. They were free to stop participation in the tests at 
any time without any consequences. This validation study with 30 participants 
was commissioned by the Haag-Streit AG, Köniz, Switzerland. 
2.2.1 Perimetric examination procedure 
After the calibration of the perimeter the adequate software settings were 
chosen. A correction of spherical and cylindrical refraction was obtained, if 
necessary, by thin-rimmed glasses put into a movable holder before the start of 
the examination for examinations inside the central 30°. Adequate near 
correction was achieved by an age-dependent near addition in accordance with 
the following table (table 2) and subsequent fine tuning, so that the patient could 
see the fixation target in focus. 
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Table 2: Age-dependent spherical near addition for Octopus 900 
Age [years ] Near correction [dpt] 
40-44 + 1.0  
45-59 + 1.5  
50-54 + 2.0  
55-60 + 2.5  
>60 + 3.0  
 
Cylindrical correction was applied if cylindrical ametropia was greater or equal 
to 1 dpt. For examinations beyond the central 30° of the visual field (as it is for 
the peripheral part of the grid 84-NO) no correction lenses were applied. A white 
half-transparent eye patch was used to cover the not-examined eye. The 
patients’ position was maintained with the face resting on the chin and forehead 
rest. 
 
Adequate instructions to the test subject are mandatory in order to achieve 
reliable and reproducible results [8,10]. The examiner explained the course and 
purpose of the examination and how to use the patient-response button. A 
rather conservative policy of only pushing the button, if sure to have seen a 
point, has been chosen for this study. The same investigator explained and 
conducted all examinations of all patients with standardized instructions in order 
to maintain identical conditions for each examination [10,11]. Furthermore, 
fixation control and supervision of vigilance and reliability during the 
examination were crucial tasks of the examiner. If, for example, spontaneous 
waves of contraction and dilation of pupil size were observed which indicate 
increasing sleepiness of the patient [37], the investigator was responsible to 
alert the patient. Throughout the examination the position and the vigilance of 
the patient was monitored via infrared camera. Adjustment of the chin rest and 
glass holder was done throughout the whole examination in order to ensure an 
optimal positioning of the patient at any time. 
 
Since poor fixation may lead to underestimation of depth and extent of visual 
field defects, fixation was controlled by the investigator via an infrared camera.  
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Poor fixation was addressed by the investigator’s verbal feedback to the patient 
and by correction of the chin rest. Stable fixation was also supported by prior 
instructions: Patients were told that they will not see half of the stimuli due to the 
examination strategy, so that they should not give up on fixation if there was no 
perception of stimulus for several seconds. Stimulus presentation was repeated 
automatically, if the eye was found to be closed during initial presentation. 
 
After the examination all results were saved as *.txt-files (GATEp) or *.pid-files 
(EyeSuite Perimetry) on the computers at the laboratory of the eye clinic 
Tuebingen and were also printed.  
2.3 Technical data 
2.3.1 Hardware (examination devices) 
All examinations were executed using perimeters of the Octopus 900 series.  
The three perimeters differed mainly with respect to the maximum stimulus 
luminance, which was 318 cd/m² (1000 asb) for serial device 104 (GATEp), 
1273 cd/m² (4000 asb) for serial device 894 (GATEe894) and 3183 cd/m² 
(10,000 asb) for serial device 1075 (GATEe1075), respectively. 
 
The perimeters were connected via an Ethernet link to a computer or laptop that 
controlled the perimeters via the perimetry software and stored the obtained 
data.  
 
The Octopus 900 perimeter is an automatic projection perimeter with a 
spherical, Goldmann type cupola design which allows testing of the entire visual 
field including the periphery (temporally). Kinetic as well as static or flicker 
perimetry may be accomplished both in the 30° and 90° range. The cupola has 
a radius of 300 mm (by this being in accordance with the Goldmann bowl). Test 
zones can be measured up to the following levels of eccentricity: nasal 60°, 
temporal 89°, superior 60° and inferior 70°. The outer dimensions of the 
28 
 
perimeter are:  648 mm (width) x 519 mm (length) x 796 mm (height). It weighs 
25 kg. 
 
Background luminance is based on two light sources of several LEDs and 
controlled by a separate light sensor. DLS up to 47 dB may be measured with a 
measurement accuracy of 0.5 dB. Various stimulus sizes (Goldmann I-V) can 
be presented within pre-specified stimulus intervals (adaptive – 4 sec) and for 
various stimulus durations (100ms, 200ms, 500ms) at different background 
luminance levels (1.27 cd/m² or 10 cd/m²). In this study, the background 
luminance was 10 cd/m2 for all instruments. Green-lighted markers (diamond) 
were chosen as fixation targets, because they allow testing of the foveal 
differential luminance threshold. 
 
The most recent generation of Octopus perimeters (serial device 1075) uses 
LEDs which slightly change the spectrum of background illumination and allow 
for higher maximum stimulus luminance levels, while the older Octopus 
perimeters (serial devices 104 and 894) use bulbs.  
 
A permanent infrared videopupillography based fixation control is possible, 
because the examined eye is illuminated with infrared LEDs throughout the 
examination and recorded by a CMOS ("Complementary Metal Oxide Silicon") 
camera. The image of the eye is shown on the LCD (liquid crystal display) 
display. The investigator is able to monitor the vigilance of the patient and 
assure a precise positioning of the eye by a motorized fine-adjustment of the 
chin rest at any time throughout the examination. 
 
Stimuli are projected onto the inner cupola surface via a mirror projection 
system. The stimulus intensity is controlled by a light sensor that is also a 
reference point for the system of coordinates for test locations. [38] 
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2.3.2 Software 
Two different software versions of the GATE algorithm were applied: 
1) The original prototype GATE software (GATEp) developed by U. Schiefer 
and J. Paetzold, university eye clinic Tuebingen, a fast-thresholding 
estimation software based on a 4-2-dB staircase principle.  
2) The commercially available EyeSuite© Perimetry software with the 
incorporated GATE software (GATEe), Haag-Streit AG, Köniz, 
Switzerland. 
 
The basic settings for the examinations were set as identical as possible for 
both software versions. 
2.3.2.1 Settings that were the same for GATEp and GATEe 
Kind of examination:  Static  
Stimulus method:   Standard  
Stimulus/background:  W/W (white on white) 
Stimulus size:   Goldmann III 
Presentation duration:  200 ms 
Background luminance:  10cd/m² (31.4 asb) 
Examination program:  30A, 84NO  
Fixation control:   Off  
Fixation target:   Cross markers (diamond) 
Eye:     OD (right eye) – OS (left eye) 
2.3.2.2 Settings that were different for GATEp and GATEe 
Due to methodological reasons some settings were not identical for the two 
software versions (see table 3).  
For GATEe the first examination with the chosen strategy “GATE” automatically 
applies the GATE-i algorithm and the subsequent examinations automatically 
use the GATE algorithm when selecting the button “same examination as last 
time”. For the first examination with GATEp, GATE-i and five anchor points 
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have to be chosen manually. For the second examination GATE is the chosen 
examination strategy automatically. 
Due to a misleadingly labelled scale of the EyeSuite software two different 
interstimulus intervals were chosen inadvertently: GATEp: 1200ms, GATEe: 
1500ms. 
Also, the percentage of catch trials was different GATEp: 2%, GATEe: 10%.  
Furthermore, only with the GATEp version five test locations were tested twice 
for evaluating the short-term-fluctuation.  
 
Table 3: Differing settings for GATEp and GATEe 
 GATEp GATEe 
GATE-i initial points  5  4 (automatic) 
Response interval 1200 ms 1500 ms 
Catch trials 2%  10%  
 
2.3.3 Test grids 
Two different concentric test point arrangements were used for the 
examinations. The stimuli were arranged according to a polar coordinate 
system straddling the vertical and horizontal median, in order to facilitate 
detection of visual field defects respecting the nasal step or the vertical midline. 
[5,39] 
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Figure 1: grid 30A 
 
Figure 2: grid 84NO 
 
Test grid 30A (see figure 2) covering the central 30° of the visual field by 
examining 83 test points was applied for glaucoma patients, AION patients and 
patients with chiasmal or postchiasmal visual pathway lesions, altogether 24 
subjects. Test grid 84NO (see figure 3) examines 109 test points covering 
almost 90° of the visual field. When applying this grid, the central 30° of the 
visual field were tested first. Refraction correction glasses had to be removed 
before continuing with the examination of the peripheral parts of the visual field 
beyond 30° eccentricity. Grid 84NO was used for patients with retinitis 
pigmentosa, altogether 6 patients.  
 
When comparing the test point arrangements of GATEp and GATEe several 
test points were identified that had to be excluded from the analysis for different 
reasons: 
For grid 30A eleven test points were excluded (see figure 3): The DLS results of 
five test locations (location IDs: 1, 26, 28, 30, 32) had to be excluded because 
they were tested twice by GATEp for the assessment of short-term-fluctuation. 
Their “twin” location IDs (0, 25, 27, 29, 31) were included and analysed. Two 
points (location IDs: 36 and 52, examining the blind spot) had to be excluded 
because they were not tested by GATEe at all and four points (location IDs: 80, 
81, 86, 87, temporal rim points) had to be excluded because the coordinates of 
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these location IDs were not identical for the respective test grid versions of the 
two software versions. The remaining 77 points were analysed. 
 
Figure 3: excluded test locations of grid 30A 
IDs 1, 26, 28, 30, 32 apply to the second testing of these locations. The results of the first 
testing have been included into the analysis (ID 0, 25, 27, 19, 31). IDs 36, 52 were not tested by 
GATEe, IDs 80, 81, 86, 87 had different coordinates for GATEe 
 
For grid 84NO fourteen test points were excluded from the analysis (see figure 
4): Three test points (location IDs: 21, 23, 24, examining the blind spot) were 
not tested by GATEe and eleven test points (location IDs: 41, 42, 43, 46, 47, 50, 
51, 54, 55, located on the 30° rim, and location IDs 107, 108, examining the 
most peripheral temporal locations) had differing coordinates for the location 
IDs of GATEp and GATEe. Altogether, 95 points could be included.  
See Appendix for tables of location IDs. 
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Figure 4: excluded test locations of grid 84NO  
IDs 21, 23, 24 were not tested by GATEe, IDs 41, 42, 43, 46, 47, 50, 51, 54, 55, 107, 108 had 
different coordinates for GATEe 
 
After the examinations and before analysis, all results gained for left eyes were 
mirrored with respect to the vertical meridian in order to conform to the location 
IDs of the right eye grids. 
2.4 (Statistical) Analysis 
The data entry, statistical calculations and design of tables and figures were 
performed using the statistical software JMP 9.0.0.  
All 30 participants concluded both visits. Unfortunately, the EyeSuite Perimetry 
data could not be saved for two patients (patient IDs 2203 and 2204, both 
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glaucoma patients) because of problems with the driving laptop. The GATEe 
results could therefore not be included into the analysis for these two patients. 
 
The statistical analysis was primarily heading for the following variables:  local 
DLS values, test duration, MS values. 
2.4.1 Analysis of DLS differences 
DLS values were exported from GATEp and GATEe. When the location IDs 
were checked for conformance, eleven location IDs had to be excluded from 
analysis for grid 30A and fourteen for grid 84NO (see 2.3.3 Test grids).  
The exported DLS values could not be compared immediately for two reasons: 
First, they had different units of measurement. DLS values were measured in 
[dBs] by GATEp and in [dB*10] by GATEe. This is why all GATEe results had to 
be divided by 10 first. 
Second, their reference scales were different. For GATEp the reference value 
was the background luminance of 10 cd/m² (31.4 asb) with the measurement 
unit dBs (standardized dB scale). For GATEe, however, the scales were 
referenced to the maximum stimulus luminance, which was 1273 cd/m² (4000 
asb) for serial device 894 and 3183 cd/m² (10,000 asb) for serial device 1075, 
respectively. This correlates with an offset of 4 dB between the two perimeters.  
Because of the logarithmic scale, a translation from one scale to the other is 
performed by subtraction or addition of a given value. [1] 
Therefore, the DLS values measured by serial device 1075 were subtracted by 
4 and the DLS values measured by GATEp were added to 22, in order to 
achieve comparable dB-scales. 
For serial device 1075 all negative results were set to 0 dB, in order to factor out 
small differences in places of almost absolute defect. 
 
When deciding whether a new method may be used instead of an already 
established method, there are two essential aspects: First, the amount of 
agreement between the two methods and second, the clinical evaluation of the 
differences. 
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2.4.1.1 Statistical agreement 
For the assessment of the statistical agreement of the different examinations 
the approach by Bland and Altman [40] was applied. 
 
In order to estimate the repeatability of static visual field examinations with the 
GATE software, replicate examinations were performed with GATEp. [41] The 
statistical agreement between GATEp1 and GATEp2 represents the retest-
reliability of GATE. Secondly we assessed the agreement between GATEp1 
and GATEe894 and between GATEp1and GATEe1075. 
 
Bland-Altman plots were modified and drawn for the different comparisons as 
follows (separately for the different grids): Average DLS values of each test 
location of the examinations of all included patients were plotted against their 
differences. The bias was defined as the median difference (instead of the 
mean) of the DLS values of these examinations and was depicted by a 
horizontal line. Furthermore, the 2.5 and the 97.5 percentile of the DLS 
differences (instead of ± 1.96 standard deviation) were established in order to 
specify the so-called limits of agreement (LOA) and also depicted by horizontal 
lines. 95% of the differences between the measurements were therefore 
assumed to lie within these limits. 
Like this, the statistical agreement between the methods was specified by the 
bias that represents a possible systematic error and the limits of agreement that 
represent the spread of differences between the measurements. [42] 
2.4.1.2 Clinical evaluation criteria and literature criteria 
This statistical agreement was categorised by clinical evaluation criteria (see 
table 4). Taking into account the final step size of 2 dB for the GATE algorithm 
[13,43], the measurement accuracy of 0.5 dB of the Octopus 900 perimeters 
and an assumed short term fluctuation of 1.5 dB (normative value for Octopus 
101) [44], the following criteria have been defined in advance: 
Very good agreement was stated for LOA ≤ 3 dB and a bias ≤ 0.5 dB, good 
agreement for LOA ≤ 4 dB and a bias ≤ 1 dB, acceptable agreement for LOA  
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≤ 5 dB and a bias ≤ 2 dB, respectively. LOA > 5 dB and a bias > 3 dB would 
indicate insufficient agreement and were rated as not acceptable. 
Table 4: clinical evaluation criteria 
Clinical evaluation LOA Bias 
Very good agreement ≤ 3 dB ≤ 0.5 dB 
Good agreement ≤ 4 dB ≤ 1 dB 
Acceptable agreement ≤ 5 dB ≤ 2 dB 
Not acceptable > 5 dB > 3 dB 
 
Before the evaluation of the data the LOA were corrected by subtraction of the 
bias (cLOA, corrected limits of agreement), because the criteria mentioned 
above are based on the assumption of a bias of 0 dB. 
 
Furthermore, since variance of measurements should not imitate or conceal a 
real progression of visual field defect, criteria were retrieved from recent 
literature that would indicate worsening or new detection of visual field defects. 
Differences exceeding these limits would be rated as not acceptable.  
According to the recent literature [33,45–48] the aberration between GATEp 
and GATEe should not exceed ± 5 dB in more than two test locations of the 
examined part of the visual field. There should not be more than two adjoining 
test points with an aberration greater than 5 dB. Edge points may be ignored.  
 
2.4.2 Analysis of examination duration 
Examination durations of GATE-i and GATE were assessed and compared for 
GATEp and GATEe. Since the median is more robust concerning outlier values 
than the mean, we took the median to describe the duration of examination. The 
statistical spread was specified by the 2.5 and the 97.5 percentile. 
 
Unfortunately, some settings were different for the two versions of the software 
(see also 2.3.2.2): The stimulus interval for GATEe was 1500ms, whereas it 
was only 1200ms for GATEp. In GATEp approximately 4% of all questions were 
catch trials plus fixation controls, whereas GATEe catch trials made up 10% of 
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all presentations. Furthermore, GATEp had a higher number of questions due to 
a double testing of 5 test points in order to calculate short-term fluctuation for 
grid 30A. This is why an additional re-analysis of test times was done assuming 
the same stimulus interval setting for both software versions and excluding 
catch trials and stimuli that were presented in order to estimate short-term-
fluctuation. 
First, catch trial (positive, negative) and fixation control questions were 
eliminated from the number of questions asked (NQA). Second, for grid 30A 
and GATEp the mean number of questions needed to re-estimate the 5 points 
for the calculation of short-term-fluctuation were subtracted. Third, the 
difference between the stimulus interval of GATEp (1200ms) and GATEe 
(1500ms) of 300ms was subtracted of the test times per question. Afterwards 
the adjusted test times per question were multiplied with the adjusted numbers 
of questions asked and the resulting test times were compared. All this was 
done in order to assess hypothetical test times for both software versions with 
as consistent preconditions as possible. 
2.4.3 Analysis of MS values 
An important index of visual field evaluation is the mean defect (MD), which 
indicates the mean deviation of the individual hill of vision from the age-adjusted 
normative hill of vision. The MD is the mean of all defect values of a visual field. 
Defect values are calculated by subtracting the actually estimated DLS from the 
normative age-correlated sensitivity values. Since different normative values 
were underlain for the calculation of defect values in the different software 
versions (GATEp: normative values for presentation duration of 200ms, GATEe: 
normative values for presentation duration of 100ms), the MD values were not 
comparable. This is why, even though MD is the more relevant value to be 
analysed in perimetry studies, mean sensitivity (MS) values have been 
compared instead. MS is defined as the mean of all sensitivity values (DLS) of a 
visual field. Like MD it is a sensitive index of diffuse visual field loss, but can 
also be influenced by focal defects of sufficient depth or extent. [44] 
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Median MS values were assessed for the different serial devices and their 
range was specified by the 2.5 and the 97.5 percentile. 
3. Results 
3.1 Differential Luminance Sensitivity 
3.1.1 GATEp1 vs. GATEp2 (Test-Retest-Reliability)  
The comparison of GATEp1 vs. GATEp2 was done in order to specify the 
statistical agreement of GATEp. See figure 5 for results of grid 30A and figure 6 
for results of grid 84NO. The modified Bland-Altman plots do not show trends, 
the differences do not tend to get larger with increasing average. Also, the 
variability of differences stays consistent across the graph. The results show 
very good agreement according to the clinical evaluation criteria. 
 
For a summary of the maximum, minimum and median differences and the LOA 
of the examinations performed with GATEp as taken from the Bland-Altman 
plots see table 5. Table 6 shows the results separately for GATE-i and GATE.  
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Figure 5: GATEp1 vs.GATEp2, grid 30A 
Modified Bland Altman-plot of the examinations performed with GATEp1 and GATEp2 applying 
grid 30A. The Limits of agreement are depicted by the 97.5- and the 2.5-percentile. The bias is 
depicted by the median of differences between GATEp1 and GATEp2. For the sake of a faster 
valuation of the graph, a bias of 0 dB has also been depicted by a narrow line. 
The x-axis shows the average DLS values per test location for the two examinations. The y-axis 
shows the difference of the achieved DLS values per test location of the examination with 
GATEp1 subtracted by GATEp2. All values are in dB 
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Figure 6: GATEp1 vs. GATEp2, grid 84NO 
Modified Bland Altman-plot of the examinations performed with GATEp1 and GATEp2 applying 
grid 84NO. For explanation of abbreviations see figure 5 
 
 
Table 5: Overview of bias and LOA and clinical evaluation criteria for GATEp1-
GATEp2 
Overview of bias and LOA for GATEp1 vs. GATEp2 
Clinical evaluation 
criteria 
Grid 
Min. 
[dB] 
Max. 
[dB] Bias [dB] 
LOA (2.5%-
97.5%) [dB] 
cLOA 
[dB] Bias  cLOA  
30A -2.5 2.8 0.4 -1.9 to 2.2 -2.3 to 1.8 Very good Very good 
84NO -2.5 3.3 0.0 -1.7 to 2.1 -1.7 to 2.1 Very good Very good 
Min. = minimum difference of DLS values between the two examinations 
Max. = maximum difference of DLS values between the two examinations 
Bias = median difference of DLS values between the two examinations 
LOA = limits of agreement, i.e. 2.5- and 97.5-percentile 
cLOA = corrected limits of agreement: LOA subtracted by the bias 
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Table 6: Overview of bias and LOA and clinical evaluation criteria for GATEp1-
GATEp2 regarding GATE-i and GATE separately  
Overview of bias and LOA for GATEp1 vs. GATEp2 
Clinical evaluation 
criteria 
 
Grid 30A 
Strategy 
Min. 
[dB] 
Max. 
[dB] Bias [dB] 
LOA (2.5%-
97.5%) [dB] 
cLOA 
[dB] Bias  cLOA  
GATE-i -3.5 3.1 0.4 -2.5 to 2.6 -2.9 to 2.2 Very good Very good 
GATE -1.8 4.2 0.4 -1.6 to 3.1 -2.0 to 2.7 Very good Very good 
 
Grid 84NO 
Strategy 
Min. 
[dB] 
Max. 
[dB] Bias [dB] 
LOA (2.5%-
97.5%) [dB] 
cLOA 
[dB] Bias  cLOA  
GATE-i -3.5 5.2 0.0 -2.9 to 3.9 -2.9 to 3.9 Very good Very good 
GATE -2.5 3.0 0.1 -1.9 to 2.5 -2.0 to 2.4 Very good Very good 
For explanation of abbreviations see table 5 
 
When evaluating the DLS results that were taken from the modified Bland-
Altman plots comparing GATEp1 versus GATEp2 the cLOA values and biases 
show very good agreement for both grids. For grid 30A the median values of the 
differences indicate a small bias (0.4 dB), whereas no bias is found for grid 
84NO. 
The comparison of the LOA between GATE-i and GATE (as shown in table 6) 
shows larger LOA for GATE-i. This represents a greater variability for the initial 
examinations. 
3.1.2 GATEp1 vs. GATEe894 (Comparison with Eyesuite, serial device 894) 
For the assessment of the statistical agreement between GATEp and GATEe 
the results of the examination with GATEp1 (first examination with GATEp) and 
GATEe894 (examination with GATEe on serial device 894, maximum stimulus 
luminance of 1273 cd/m² [4000 asb]) were compared. The Bland-Altman plots 
for the comparison of GATEp1vs. GATEe894 are shown in figures 7 and 8 for 
the two different grids. The information that can be drawn from these plots is 
summarised in table 7. 
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Figure 7: GATEp1 vs. GATEe894, grid 30A 
Modified Bland Altman-plot of the examinations performed with GATEp1 and GATEe894 
applying grid 30A. For explanation of abbreviations see figure 5 
 
For grid 30A a bias of 1.5 dB is observed. This indicates systematically higher 
threshold values for GATEp1 compared to GATEe894. The same is observed – 
but only to a small extent (0.5 dB) - for grid 84NO. The differences between 
GATEp and GATEe, i.e. the range of the LOA, are greater than those between 
GATEp1 and GATEp2. 
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Figure 8: GATEp1 vs. GATEe894, grid 84NO 
Modified Bland Altman-plot of the examinations performed with GATEp1 and GATE894 
applying grid 84NO. For explanation of abbreviations see figure 5 
 
Table 7: Overview of bias and LOA and clinical evaluation criteria for GATEp1 
vs. GATEe894 
Overview of bias and LOA for GATEp1 vs. GATEe894 
Clinical evaluation 
criteria 
Grid 
Min. 
[dB] 
Max. 
[dB] Bias [dB] 
LOA (2.5%-
97.5%) [dB] 
cLOA 
[dB] Bias cLOA 
30A -2.2 4.6 1.5 -1.3 to 3.9 -2.8 to 2.4 Acceptable Very good 
84NO -1.3 4.2 0.5 -0.6 to 3.0 -1.1 to 2.5 Very good Very good 
For explanation of abbreviations see table 5 
 
When applying the clinical evaluation criteria, GATEp1 and GATEe894 show 
acceptable to very good agreement for grid 30A and very good agreement for 
grid 84NO. 
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Table 8: Overview of bias and LOA and clinical evaluation criteria for GATEp1 
vs. GATEe894 regarding GATE-i and GATE separately  
Overview of bias and LOA for GATEp1 vs. GATEe894 
Clinical evaluation 
criteria 
 
Grid 30A 
Strategy 
Min. 
[dB] 
Max. 
[dB] Bias [dB] 
LOA (2.5%-
97.5%) [dB] 
cLOA 
[dB] Bias cLOA 
GATE-i -3.1 4.6 1.5 -2.2 to 4.5 -3.7 to 3.0 Acceptable Good 
GATE -1.8 5.1 1.6 -1.4 to 4.7 -3.0 to 3.1 Acceptable Good 
 
Grid 84NO 
Strategy 
Min. 
[dB] 
Max. 
[dB] Bias [dB] 
LOA (2.5%-
97.5%) [dB] 
cLOA 
[dB] Bias cLOA 
GATE-i -2.4 6.7 0.4 -2.1 to 5.3 -2.5 to 4.9 Very good Acceptable 
GATE -1 4.3 0.7 -0.8 to 3.8 -1.5 to 3.1 Very good Good 
For explanation of abbreviations see table 5 
 
The range of LOA is again greater for GATE-i than for GATE (see table 8). The 
clinical evaluation criteria also show acceptable to very good agreement 
between GATEp and GATEe. 
3.1.3 GATEp1 vs. GATEe1075 (Comparison with Eyesuite, serial device 
1075) 
The results of the examinations with GATEp1 (first examination with GATEp) 
and GATEe1075 (examination with GATEe on serial device 1075, maximum 
stimulus intensity of 3183 cd/m² (10,000asb)) were also compared.  
Table 9: Overview of bias and LOA and clinical evaluation criteria for GATEp1 
vs. GATEe1075 regarding GATE-i and GATE separately  
Overview of bias and LOA for GATEp1 vs. GATEe1075 
Clinical evaluation 
criteria 
 
Grid 30A 
Strategy 
Min. 
[dB] 
Max. 
[dB] Bias [dB] 
LOA (2.5%-
97.5%) [dB] 
cLOA 
[dB] Bias cLOA 
GATE-i -2.4 4.6 1.0 -1.5 to 4.4 -2.5 to 3.4 Good  Good  
GATE -2.9 4.1 1.2 -2.5 to 3.7 -3.7 to 2.5 Acceptable  Good  
 
Grid 84NO 
Strategy 
Min. 
[dB] 
Max. 
[dB] Bias [dB] 
LOA (2.5%-
97.5%) [dB] 
cLOA 
[dB] Bias cLOA 
GATE-i -2.2 6.4 0.5 -1.8 to 5.1 -2.3 to 4.6 Very good Acceptable 
GATE -0.9 3.9 0.8 -0.4 to 3.3 -1.2 to 2.5 Good Very good 
For explanation of abbreviations see table 5 
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Table 9 shows the biases and LOA of the comparison of GATEp1 and 
GATEe1075. Again, the clinical evaluation criteria state acceptable to very good 
agreement of the examinations. For grid 84NO the biases are comparable to 
those of the comparison with GATEe894. For grid 30A they are a little smaller. 
3.1.5 Results regarding the literature criteria 
Five test locations showed deviations between the examinations exceeding 5 
dB. See table 10 for an overview of these locations.  
They all show greater sensitivities for GATEp1 than for GATEe. There were no 
adjoining or paracentral test locations exceeding the 5 dB limits.   
 
The grid 30A exception only exceeded the 5 dB by 0.1 dB. Its location ID 39 
belongs to a midperipheral point in the superior temporal quadrant (see figure 
9). Except for this one, all other test points exceeding the 5 dB deviation limits 
occurred with RP patients (grid 84NO) performing GATE-i. See figure 10. 
Location ID 44 and location ID 53 are locations at the border of the central 30° 
visual field potentially interfering with the rim of the near correction glasses. As 
stated above, border points may therefore be ignored.  
Location ID 27 is a midperipheral point in the lower nasal quadrant, not 
adjoining the other location IDs. This test location is either part of or directly 
adjacent to a scotoma in the visual fields of all patients examined with this grid. 
It is the only point, where the 5 dB limit is exceeded twice (for the comparison of 
GATEp1 with both GATEe894 and GATEe1075).  
Location ID 10 is a rather central, but not paracentral point of the superior nasal 
quadrant. It was perceived by only half of the patients. 
 
The following figures show the location of these test points within the grids. 
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Figure 9: Test location exceeding the 5 
dB deviation limit, grid 30A 
 
 
 
Figure 10: Test locations exceeding the 
5 dB deviation limit, grid 84 NO 
Table 10: Overview of the test points exceeding the 5 dB deviation limit 
Grid Examination Location ID 
Eccentricity/angle 
[°/°] 
Difference 
[dB] 
84NO GATEp1 vs. GATEp2 GATE-i 44 (30.0/86.2) 5.2 
 GATEp1 vs. GATEe894 GATE-i 53 (30.0/-86.2) 5.6 
  27 (17.5/-135.0) 6.7 
 GATEp1 vs. GATEe1075 GATE-i 27 (17.5/-135.0) 6.4 
  10 (9.9/78.3) 5.5 
30A GATEp1 vs. GATEe894 GATE 39 (15.0/74.9) 5.1 
 
3.2 Examination duration 
Table 11 shows all test durations. GATE-i (i.e. the initial session) took 1.5 min 
(median value) longer than GATE (i.e. the subsequent session) for all 
perimeters as had been expected.  
Overall median test duration (including both grids and examinations) of GATEp 
was 8.6 min (2.5, 97.5 interval:  5.5 min, 11.6 min), for GATEe 9.3 min (2.5, 
97.5 interval: 6.3 min, 12.4 min).  
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Table 11: Overview of examination durations [min] 
 
GATE-i GATE 
Median 
2.5-
percentile 
97.5-
percentile 
Median 
2.5-
percentile 
97.5-
percentile 
30A  
GATEp1 9.2 7.8 11.6 7.7 6.0 9.6 
GATEp2 9.3 7.4 11.1 7.9 6.0 8.7 
GATEe894 9.9 7.8 11.2 8.8 7.1 10.7 
GATEe1075 9.4 8.1 10.9 8.7 6.3 12.2 
       
84NO  
GATEp1 9.9 9.2 12.5 6.4 5.3 8.4 
GATEp2 9.6 9.0 12.9 7.0 5.2 8.3 
GATEe894 10.8 7.2 12.4 7.6 6.3 9.1 
GATEe1075 10.5 8.6 13.3 7.1 6.2 9.1 
 
3.2.1 Simulation of test times assuming identical settings. 
Table 12: Examination duration per question for the four perimeters 
Serial device 
GATE-i GATE 
Test time 
[min] NQA 
Time / 
question [s] 
Test time 
[min] NQA 
Time / 
question [s] 
GATEp1 9.4 326 1.74 7.5 283 1.60 
GATEp2 9.5 338.5 1.69 7.7 280 1.65 
GATEe894 10.1 290 2.09 8.6 250.5 2.06 
GATEe1075 9.7 298.5 1.94 8.6 266 1.94 
NQA = number of questions asked 
 
When dividing the test time by the number of questions asked (NQA) - see table 
12, it becomes clear that the test time per question was shorter for GATEp than 
for GATEe by approximately 300 ms for GATE-i and 375 ms for GATE. This 
was probably due to the different settings for the interstimulus interval. 
However, the test time per question was 120 ms - 150 ms longer for GATEe894 
compared to GATEe1075, even though the settings for those examinations 
were exactly the same. Reasons for that should probably be sought in special 
characteristics of serial device 894 that used to pause shortly during some 
examinations without apparent reason, maybe because of problems with the 
driving laptop. 
 
By subtracting the number of catch trials and the number of questions asked for 
the estimation of short-term-fluctuation from the overall number of questions 
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asked, we assessed the number of questions that were just and only asked in 
order to determine the DLS. Short term fluctuation was only assessed for grid 
30A on serial device 104. Table 13 shows the results. All values in this table are 
median values. 
Table 13: Calculation of adjusted number of questions 
Serial device 
GATE-i GATE 
grid - catch trials -SF grid 
 
- catch trials -SF 
1104 30A 310 292.4 30A 275 259.4 
84NO 292.5  84NO 200.5  
2104 30A 322 303.7 30A 285.5 269.6 
84NO 285  84NO 214  
894 30A 260.5   30A 228.5   
84NO 273.5  84NO 193.5  
1075 30A 259   30A 240.5   
84NO 288.5  84NO 194  
SF = number of questions asked for the assessment of short term fluctuation  
 
After that the test times per questions of GATEe were adjusted by subtracting 
300 ms, which is the difference between the stimulus intervals of GATEp and 
GATEe. Afterwards the adjusted test times per question were multiplied with the 
adjusted numbers of questions. See table 14 for the resulting adjusted test 
times. All values are median values. 
 
Table 14: Adjusted test times  
Serial device 
GATE-i GATE 
Adjusted 
test time 
[min] 
Adjusted 
NQA  
Adjusted 
time / 
question [s] 
Adjusted 
test time 
[min] 
Adjusted  
NQA 
Adjusted 
time / 
question [s] 
30A 
1104 8.5 292.4 1.74 6.9 259.4 1.60 
2104 8.6 303.7 1.69 7.4 269.6 1.65 
894 7.8 260.5 1.79 6.7 228.5 1.76 
1075 7.1 259 1.64 6.6 240.5 1.64 
84NO 
1104 8.5 292.5 1.74 5.3 200.5 1.60 
2104 8.0 285 1.69 5.8 214 1.65 
894 8.2 273.5 1.79 5.7 193.5 1.76 
1075 7.9 288.5 1.64 5.3 194 1.64 
NQA = number of questions asked 
 
After these transformations for enhancing comparability table 14 now shows 
similar test times for GATEp and GATEe. 
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3.3 Mean sensitivity (MS) 
When looking at the MS values of the different groups of patients, AION and 
glaucoma patients, who suffer from similar visual field defects,  show similar MS 
values (about 17.7dB). The MS of patients with (post-) chiasmal lesions is 
higher than for the other patients (about 20.0 dB). RP patients who suffer from 
an essential constriction of the visual field achieve the lowest MS values of 
approximately 5.2 dB in median.  
 
When analysing the median MS values for the different perimeters, serial 
devices 104 and 894 show comparable median MS values with only slightly 
higher results for 894. The median MS value of serial device 1075 
(GATEe1075, higher maximum stimulus intensity) is about 5 dB higher (median 
value) than that of the perimeters with lower maximum stimulus intensity. This 
effect can still be observed, even if median MS values are calculated for the 
different visits (GATE and GATE-i) and for the different diseases (see table 15).  
The greatest differences between serial devices 1075 and 104 (GATEp) were 
found for AION and glaucoma patients (approximately 6 dB), who are mainly 
suffering from relative scotomas. For hemianopia patients the difference is 
approximately 4.5 dB and for RP patients only 2.5 dB (see also Table 15). 
Median MS values are smaller for GATE compared to GATE-i by approximately 
1 dB, except for serial device 1075. 
 
In summary, MS values of 104 and 894 are comparable, but examinations done 
with serial device1075 achieve higher MS values, especially for patients with 
relative scotomas. 
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Table 15: Median MS values overview  
 
 
1104 (GATEp1) 2104 (GATEp2)  
894 
(GATEe894) 1075 (GATEe1075) 
 
Median MS (2,5 percentile, 97.5 percentile) [dB] 
Overall results for the different perimeters 
 
15.6 (0.8, 23.7) 14.7 (0.6, 23.4) 15.9 (2.0, 23.8) 20.2 (2.9, 28.2) 
 
Groups of diseases 
 
AION 
 
16.1 (14.1, 20.0) 15.3 (13.6, 20.8) 15.8 (13.7, 22.8) 22.0 (19.5, 28.2) 
 
Glaucoma  16.9 (5.7, 23.7) 16.4 (5.2, 23.7) 16.8 (7.9, 23.8) 21.9 (9.3, 28.2) 
 
HH 
 
19.5 (13.7, 22.6) 19.4 (14.0, 23.3) 19.9 (15.5, 23.6) 24.0 (17.2, 27.2) 
 
RP 
 
4.1 (0.8, 5.9) 4.3 (0.6, 6.6) 5.2 (1.8, 7.0) 6.7 (2.7, 9.3) 
 
Visit strategy 
 
GATE-i 
 
15.9 (0.8, 23.6) 15.0 (0.7, 23.5) 16.2 (1.8, 23.8) 20.5 (2.7, 28.2) 
 
GATE 
 
14.5 (0.9, 23.7) 14.6 (0.6, 23.3) 15.9 (2.3, 23.8) 19.8 (3.1, 28.2) 
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4. Discussion 
4.1 DLS differences 
4.1.1 Clinical evaluation criteria 
 
At first glance, an aberration of 3 dB seems a rather big difference to be rated 
as very good agreement. However, a short-term fluctuation of 3 dB is supposed 
to be normal or at least inside the 95% reference interval [44]. For glaucoma 
patients (i.e. half of the patients examined in this study) short-term fluctuation is 
usually even greater than for ophthalmologically normal subjects. [49] 
Furthermore, the LOA represent a 95% reference range, which means that 
most differences were smaller than these values. But in order to not obscure 
potential progression of the disease, LOA greater than 5 dB were rated as not 
acceptable. 
Regarding the bias, differences < 0.5 dB are not relevant in clinical practice, 
since the perimeters only assess DLS with a measurement accuracy of 0.5 dB  
[38]. A bias exceeding the supposed normal short-term fluctuation (i.e. > 3 dB) 
was rated as not acceptable. 
4.1.2 Literature criteria 
There are manifold definitions regarding progression of glaucoma in various 
studies. Since in this study only local DLS values were assessed, the search 
was restricted to clinical criteria that referred to DLS. 
Several different glaucoma studies defined a worsening by at least 5-10 dB at 
2-3 adjacent test points outside the central visual field as a progression or a 
new manifestation. [45,46] For example, Anderson and colleagues defined a 
progression of glaucoma, if there was a worsening of ≥ 3 points by ≥ 10 dB in 
an existing defect or if a worsening of ≥ 2 new adjacent points by at least 10 dB 
had taken place. [47] A minimum depression of 9 dB in peripheral test locations 
and a depression of 5 dB in paracentral points are needed to elevate the score 
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indicating a progression of visual field defects in the AGIS score (Advanced 
Glaucoma Intervention Study). [48] 
This is why all test points exceeding the 5 dB deviation limit were checked for 
adjacency and their location in the visual field. Two of them were negligible 
border points. Two other test points (location ID 27 and10) were either part of or 
adjacent to scotomas for all examined patients (RP). So, due to small 
fluctuations in fixation these test points could be “swallowed up” by the adjacent 
scotomas, which could lead to great fluctuation in the perceived DLS level. 
Maximum differences between the procedures were far below 10 dB. For all test 
conditions, the upper (i.e. 97.5%) LOA values were below 5.3 dB. 
4.1.3 DLS results 
Visual field results represent a large and complex physiologic variability [50–52]. 
This threshold variability has been shown to increase with progressive 
eccentricity [53]. For glaucoma patients inter- and intra-subject variability is 
even larger [49,54] and local increase of variability within and between tests 
may even be the first visual field disturbance detectable [55,56]. Various studies 
showed that test-retest variability of threshold perimetry increases with 
decreasing sensitivity until it declines again near 0 dB (floor effect) [22,57–59]. 
All patients included in this study suffered from moderate to severe visual field 
loss. An acceptable to very good agreement could be stated for all comparisons 
between the examinations, i.e. regarding intra- and inter-subject agreement. So, 
from a clinical point of view, the agreement between GATEp and GATEe is 
sufficient. 
 
The agreement of two methods is limited by the repeatability of these methods. 
Furthermore, since variability increases with decreasing sensitivity of the visual 
field of the patients [59] and the agreement of two different methods is limited to 
their repeatability [40,41] it is not surprising that the repeatability of GATEp itself 
is better than the agreement between GATEp and GATEe. 
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A bias of approximately 1.5 dB was observed for grid 30A indicating a 
systematic tendency of GATEp to assess higher DLS values than GATEe. This 
may be due to the methodological differences between the two procedures [42]. 
For grid 84NO this bias is only approximately 0.5 dB. The comparatively small 
bias is probably the result of a ceiling effect due to the extended visual field 
losses resulting from the advanced disease of the RP patients. When 
comparing SITA algorithms with the FT strategy, biases of approximately 1 dB 
have been found [57,60]. Since perimetric examinations should usually be 
evaluated by follow-up examinations and trend analysis, they should be 
performed with the same software and strategy for each examination. 
Therefore, such systematic errors should not relevantly deform visual field 
results or impact visual field evaluation. 
 
GATE utilizes local thresholds from previous examinations instead of testing 
starting points (like GATE-i). This saving of time is very valuable in a clinical 
setting. Furthermore, the results may be more accurate and repeatable [30]. 
However, the risk to bias the results toward previous findings could increase in 
cases of immediate and pronounced change, like for example inflammation, 
trauma or infarction. Such a case would result in a prolonged threshold 
approach due to the assumption of (in the meantime) invalid previous local 
threshold values. However, the majority of ophthalmological diseases that need 
follow-up shows chronic progression like for example glaucoma, compressive or 
hereditary optic neuropathy or degenerative retinal diseases like age-related 
macular degeneration or tapeto-retinal degeneration. For these patients 
immediate changes are rarely the case. To assume normal conditions in these 
patients and neglect previous findings could result in a considerable 
prolongation of test duration and could therefore provoke fatigue.  
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4.2 Examination duration 
4.2.1 Comparison of GATE-i and GATE 
Longer test durations for GATE-i than for GATE were to be expected, since 
GATE-i examines more test points and refers to age-related standard values 
instead of taking the patients’ last examination as the basis for the starting 
luminance of the test points. 
4.2.2 Comparison of GATEp and GATEe 
The unexpectedly longer examination durations of GATEe of partly up to one 
minute (i.e. approximately 8%) are probably explained by the different settings, 
especially due to the fact that the presentation interval for GATEp was only 
1200 ms compared to 1500 ms for GATEe (300 ms difference, i.e. 25% longer 
intervals). These settings were different, because the stimulus interval could be 
typed in for GATEp, but had to be chosen from a regulator with predetermined 
values for GATEe. The labeling of the regulator led to believe that the same 
stimulus interval had been chosen. The real stimulus interval was not 
accessible before the end of the examinations. Hence, a simulation of test times 
assuming identical settings that indicated similar test times, was performed. 
It has to be mentioned, however, that the calculations only offer an 
approximation of possible examination durations, since a change in stimulus 
interval may possibly have an influence on response behavior. Assuming an 
adequate approximation, the incorporated GATEe strategy offers the same 
advantages as have been shown for GATEp in a prior study regarding test time 
[13]. GATEe is therefore a good alternative to any other fast-thresholding 
estimation strategy. Consistent settings should be realized in future studies in 
order to confirm the simulated results. 
4.2.3 Comparison with SITA Standard 
In several studies with patients suffering from visual field loss average or 
median test times of about 6-8 min were achieved for SITA Standard with a 24-
2 pattern (52 test locations (TL), 0.12-0.15 min/TL, i.e. 7.2-9.0 s/TL). Shorter 
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test times of about 5 min could be achieved for healthy test subjects [13,22,58]. 
The median test times for GATEe in this study with visually impaired test 
subjects were 8.8 min for grid 30A (83 TL, 0.11 min/TL, i.e. 6.6 s/TL) and 7.6 
min for grid 84NO (109 TL, 0.07 min/TL, i.e. 4.2 s/TL) [42]. If comparing the 
needed time per test location, GATEe might even be faster than SITA standard 
if the same patients were tested with the same grid. When compared to the full 
threshold (FT) strategy, GATE showed considerably shorter test times. [13] 
 
For GATE no increase of test time is observed for increasing visual field loss. 
RP patients with extended visual field loss show the shortest examination 
durations of the four groups. This is probably due to the comparatively high 
proportion of test points with absolute scotomas which do not need a time-
consuming thresholding strategy. In contrast, increasing test times for 
increasing visual loss have been shown for SITA [13,22].  
4.2.4 Test times compared to a prior study 
In a prior study of Schiefer et. al. examination durations for a group of 40 
patients with manifest glaucoma, 10 patients with suspected glaucoma and 10 
patients with ocular hypertension were 5.7 min for GATE-i and 4.7 min for 
GATE, while SITA Standard took 5.6 min and FT needed 9.0 min in the first 
study that involved the GATE algorithm [13]. In this study, however, GATE-i 
needed 9.3 min and GATE needed 7.6 min. These longer test times were 
probably due to the use of different test point arrangements. 83 and 109 test 
locations have been tested in this study, whereas pattern 24-2 grid that was 
used in the study of Schiefer et.al. only tested 53 test locations covering the 
central 24° visual field. The longer test times could also be due to the different 
sample of subjects.  
4.2.5 The effect of shorter test times on perimetric performance 
Shorter test times are supposed to reduce fatigue and reliability problems. 
Marra et al. suggested that for test times of 5-8 minutes no major trend of either 
learning or fatigue effect is observed in a single session [4]. All this should lead 
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to a higher reliability of test results due to shorter test times. Furthermore, 
patients are supposed to be more motivated and attentive and less bored by the 
examination and even patients who can only concentrate for a short period of 
time may adequately perform threshold estimating visual fields. Another 
advantage of shorter test times is time saving in clinics and practices, which is 
practical, but also economically important. 
4.3 Mean Sensitivity 
We unfortunately cannot provide the Mean Defect (MD) for the GATEe 
examinations, since the normative data base for MD of EyeSuite is referring to a 
stimulus duration of 100 ms, whereas the stimulus duration was 200 ms in our 
study, which was chosen for comparability reasons with the standard setting 
over decades for all other perimetric examinations in the university eye hospital 
in Tuebingen. This is why we assessed and compared MS values. 
4.3.1 Background luminance 
A background intensity of 10 cd/m² was chosen in this study in order to operate 
under photopic conditions. This is reasonable because for photopic adaption of 
the eye Weber’s law is valid which states that the necessary differential 
luminance (level) for stimuli rises linearly with the background luminance [34]. 
Under photopic conditions exclusively the cone photoreceptor system can be 
tested. It furthermore offers a fast adaptation for patients who have usually been 
exposed to a bright environment beforehand. Also, examination results are less 
depending on pupil size than for non-photopic conditions [61]. 
This is why a background luminance of 10 cd/m² (31.4asb) was recommended 
by the International Perimetric Society in 1978 to be the standard for perimetric 
examinations [62]. 
4.3.2 Maximum stimulus luminance and its influence on MS values 
The three different perimeters offered three different maximum luminance 
levels. This is important, because the maximum luminance is the reference 
value for the logarithmic relation scale which is the measurement unit for DLS 
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values (max. stimulus intensity = 0dB) [11] and this is the reason why the DLS 
results in dB of the different perimeters had to be translated by the above 
mentioned formulas in order to be comparable. 
 
For a comparatively dim background luminance of 1.27 cd/m² (4 asb) stimulus 
intensities higher than 318 cd/m² (1000 asb) may produce disturbing stray light. 
This can lead to an irradiation into scotoma areas and by that falsify sensitivity 
estimates and lead to an underestimation of defect depth and size [63]. This is 
why the maximum level of stimulus luminance is limited in order to prevent stray 
light, which increases with brighter stimuli leading to a replacement of local 
responses by stray-light responses [64]. In this study a remarkable increase of 
MS values was found for the perimeter with a maximum stimulus luminance of 
3183 cd/m² (10,000 asb, serial device 1075) compared to the other perimeters 
with maximum stimulus luminances of 318 cd/m² (1000 asb, serial device 104) 
and 1273 cd/m² (4000 asb, serial device 894), respectively. It is not quite 
obvious, however, if this effect is due to stray light, because in this study for all 
perimeters a background luminance of 10 cd/m² (31.4 asb) instead of 1.27 
cd/m² (4 asb) was used. If the increased MS values were due to stray light and 
not only to the reduction of scotomas, there should rather also be a noticeable 
effect on the size of the blind spot.  
 
The effect of higher MS values for higher maximum stimulus intensities was 
smallest for extended absolute scotomas (RP patients) and most pronounced 
for scotomas with higher portions of relative scotomas (glaucoma patients).  
The greatest differences of MS values between serial devices 1075 and 104 
were shown for AION and glaucoma patients (approximately 6 dB), who quite 
often suffer from relative scotomas. For RP patients, who mostly suffer from 
extended absolute scotomas the MS difference was only approximately 2.5 dB. 
The results therefore support the theory that the influence of high maximum 
stimulus intensities is greater for relative scotomas than for absolute scotomas.  
That means, even if there seemed to be an effect of software on MS values at 
first glance, this effect should rather be attributed to the higher maximum 
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stimulus intensity than to the GATE algorithm itself. This point is supported by 
the fact that MS values of serial device 894 and serial device 104 were 
comparable, but MS values estimated by serial device 1075 were relevantly 
higher.  
 
It seems logical that higher stimulus luminance levels lead to higher global MS 
in patients with areas of deep visual field loss, because stimuli with higher 
luminance levels rather provoke a reaction in these areas than stimuli with lower 
luminance levels.  The importance of the comparison of global MS values 
should therefore be discussed. Other circumstances that could possibly have an 
effect on the MD of standard automated perimetry (and by that also on MS 
values) could be time of day, season, experience of the investigator, the rate of 
false-positive responses [8] and pupil size [65]. 
4.4 Examination parameters  
4.4.1 Stimulus size 
Common standard stimulus sizes have been introduced by Goldmann. Five 
different sizes are defined by Roman numerals I (0.25mm², i.e. 6.5 min of arc) 
to V (64mm², i.e. 104 min of arc), each covering a 4-fold greater area than the 
previous stimulus size. The most commonly used stimulus size in standard 
automated perimetry is the Goldmann size III stimulus (4 mm², i.e. 26 min of 
arc) [6,11]. 
This stimulus size was also chosen in this study, because it is big enough to 
offer a good dynamic range and reduce refraction errors, but at the same time 
small enough to avoid missing detection of small scotomas. Furthermore, this is 
the mandatory stimulus size for examinations regarding expert opinion 
examinations as recommended by the Transport and Traffic Committee of the 
scientific association of ophthalmology in Germany (Deutsche 
Opthalmologische Gesellschaft) for standard automated perimetry [66]. 
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The larger the stimulus, the smaller is the influence of refraction errors and the 
greater is the dynamic range, especially in the peripheral visual field. Taravati et 
al. observed an exponential rise in variability with decreasing sensitivity for 
glaucoma patients, whereas variability stayed almost constant, if a very large 
stimulus was used [67]. Wall et al. also observed a reduction of variability and a 
slightly better repeatability of MD for the use of size V stimuli when testing 
glaucoma patients with normal or moderately damaged visual fields [68,69]. 
 
The Goldmann III stimulus size was found to be more useful for the detection of 
field aberrations in RP patients compared to a bigger stimulus size. If 
progression surveillance in RP patients would have been the aim of the 
examinations, a size V stimulus would have been more useful, however [70]. 
4.4.2 Stimulus presentation duration 
Stimulus presentation duration should not be shorter than 100 ms in order to 
prevent temporal summation (Bloch’s law) [34], but should not be longer than 
200 ms in order to prevent eliciting gaze movements towards the stimulus [1]. 
Both effects would possibly affect the results of field examination. Other studies 
say that there seems to be no relevant effect of longer stimulus presentation on 
fluctuation of perception for stimulus durations between 65 ms and 500 ms [71]. 
However, for this study the stimulus presentation duration of 200ms has been 
chosen in order to compromise the above mentioned possible limitations. 
4.4.3 Acoustic cueing  
The mirror units of perimeters with a mirror-projection system produce ambient 
noise for mechanical reasons that may indirectly announce a following stimulus 
presentation. In addition to that, each stimulus (or false-positive catch trial) was 
presented accompanied by a beep. The projection noise and the beeps are 
both acoustic cues for the patients and may potentially have either stimulated 
“trigger happiness”, annoyance of the patients and disturbance of the patients’ 
concentration or they could possibly have been a help to concentrate on the 
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other hand. Different reactions came from the patients concerning acoustic 
cueing dependent on their subjective sensations. 
For serial device 104 the signal sound beeps were presented at the same time 
as the stimulus presentation, whereas for serial devices 894 and 1075 the 
signal sounds did not coincide with stimulus presentation.  
The effect of the stimulation of trigger happiness by acoustic cueing and by that 
shorter reaction times and higher rates of false-positive responses could not be 
confirmed by Rauscher et. al. for kinetic perimetry [72]. 
Lewald et al. stated that passive auditory stimulation of the blind side may 
improve vision in hemianopia patients probably due to an activation of residual 
visual pathways [73]. However, this should have had little effect on the results of 
this study, because hemianopia patients made up for only 24% of the examined 
subjects and the acoustic cues were always presented in the same way (not 
according to the blind side of each patient). Another study showed an 
improvement of vision in hemianopia patients by improving oculomotor patterns 
after audio-visual stimulation [74]. This may probably rather affect kinetic 
perimetry than static perimetry.  It has been shown, however, that co-occurring 
acoustic stimuli may affect visual sensitivity by influencing the perception of 
visual stimuli [75]. Further studies focussing on the relationship between visual 
and acoustic perception would be very interesting and important. 
 
4.5 Patient-related parameters 
4.5.1 Inclusion and exclusion criteria 
The selection of inclusion and exclusion criteria is always a delicate issue and 
crossroads between the risk of homogeneity and stratification and the wish to 
ensure representativeness and transferability to real-life conditions. In fact, 
pregnancy and breastfeeding, may affect vision and visual field [76]. In order to 
establish stable conditions, especially with regard to test-retest reliability we 
decided to exclude pregnant and lactating women as well as subjects with 
asthma. 
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Diabetic retinopathy is characterized by a variety of potentially confounding 
impacts on ocular, cerebral and other structures, which may critically interfere 
with the intended stratification of the sample. Cerebrovascular accident has not 
been flagged as an exclusion criterion for the fourth group. 
4.5.2 Pupil size 
The pupil is the natural optical aperture of the eye, controlling the amount of 
light that is allowed to enter the eye in order to improve imaging on the retina. 
However, if pupil diameter falls to less than 2.5 mm, the edge of the pupil 
causes light diffraction resulting in an impaired resolution [77]. Webster et al. 
have shown that miosis has a considerable effect on Mean Deviation (MD), but 
does not affect pattern standard deviation, which indicates a uniform reduction 
of sensitivity caused by small pupil size [65]. Pupil size should therefore exceed 
3 mm, in order to prevent influences on the differential luminance sensitivity. 
Pupil dilatation, however, should be avoided, because the collection of 
normative data was done with normal, undilatated eyes and furthermore, 
dilatation results in changes in refraction (e.g. due to spherical aberration), 
which can also influence differential luminance sensitivity [78].  
 
Another interesting issue about pupil size and perimetry is that fatigue wave 
amplitude and miosis are indicators of decreasing vigilance of patients and can 
be documented by infrared pupillography [37,79]. 
4.5.3 Refraction 
Inadequate refractive correction may lead to perimetric outcome errors due to a 
blurred retinal image formation of the stimulus. This effect is more pronounced 
for smaller stimuli and may result in refraction scotomas [11].  
4.5.4 Patient reliability indices 
Patient reliability is an important factor for reproducibility in perimetry, because 
poor reliability may result in under- or over-estimation of differential luminance 
sensitivity.  A patient’s inattention results in false-negative responses, since the 
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patient does not respond to a supra-threshold stimulus that was previously 
perceived. The rate of false negative answers is increased in case of severe 
visual field loss and leads to an artificial increase in visual field loss [80]. False-
positive catch trials, which are characterized by patients’ responses without 
stimulus presentation, are a good predictor for “trigger happiness” or “guessing” 
of the test subject. Increased false-positive response rates result in an artificially 
reduced visual field loss. If patient reliability is decreasing during examination, 
the patient should be reinstructed [77]. Catch trials, however, offer a surprisingly 
imprecise prediction of real reproducibility of the field status [81].  
4.5.5 Learning effect 
Learning effects in inexperienced subjects performing automated static 
perimetry are common. Studies have shown that this effect is rather small and 
usually limited to the first sessions. Sensitivity may increase with perimetric 
training. These effects could be shown for normal subjects [82,83] and also for 
patients with glaucoma [84]. It is therefore important, to perform more than one 
test in order to create a reliable baseline for perimetric follow-ups.  
All patients in this study had undergone perimetric testing before. Learning 
effects should therefore have been minimized. 
4.5.6 Fatigue effect 
As perimetry is normally a rather long-lasting examination the effect of fatigue 
and decreasing vigilance has been tested before and proved to be existent and 
to influence the results of perimetric examinations. The fatigue effect, i.e. 
decreasing measured DLS values during examination, has been found in 
normal subjects [85], but also in glaucoma patients, where it resulted in the 
increasing of depth and/or size of defects. This effect is usually more 
pronounced with increasing eccentricity [86], mostly within the midperipheral 
field and with increasing age of the test subjects [87]. Shortening of test 
duration may reduce fatigue in perimetry. 
Fatigue effects should not have caused systematic errors in this study, because 
the sequence of the various methods has been randomized.  
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4.6 Statistical analysis 
Bland and Altman state that the correlation coefficient would be no indicator of 
agreement at all and the test of significance would not be relevant when asking 
for agreement [88]. Since perimetry is a technique rather biased by coincidental 
measurement errors (for example because of vigilance problems), analysis of 
regression is not an adequate approach and is also dependent on the range of 
measured values, which is also the case for the determination of the intraclass-
correlation-coefficient [41]. The plotting of average results against the 
differences between the results, however, offers an easy-to-interpret graphical 
method to explore and illustrate statistical relationships, which can also be done 
in a nonparametric approach [40], for example for small samples of data. This 
was another reason for choosing the graphical approach of Bland and Altman 
for the comparatively small sample of 30 test subjects, only allowing descriptive 
statistics.  
4.7 Future trends and perspectives  
Since GATE is not restricted to a special type of ophthalmological disease, it 
can be applied to all kinds of visual pathway lesions – in contrast to the SITA 
strategy. A great advantage of GATE is the possibility to test any (arbitrary) test 
location. This allows for individual adding of test points in regions of interest, 
thereby enhancing spatial resolution in these areas [13]. 
4.8 Conclusion 
This study shows a very good repeatability of the prototype version of the new 
fast thresholding algorithm GATE (German Adaptive Thresholding Estimation) 
with regard to differential luminance sensitivity (DLS) values and a good 
agreement between the prototype version of GATE (GATEp) and the 
commercially available version of GATE incorporated into the EyeSuite software 
package (GATEe). The results suggest that they can be used interchangeably. 
The GATE thresholding algorithm offers short examination durations and is not 
restricted to glaucomatous field loss.   
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5. Summary  
Purpose  
To validate the commercially available “EyeSuite” version of the new fast thresholding 
algorithm GATE (German Adaptive Thresholding Estimation) for automated static 
perimetry. 
Methods  
Thirty patients suffering from visual pathway lesions of various origin (anterior ischemic 
optic neuropathy [n=3], glaucoma [n=15], (post-) chiasmal visual pathway lesion [n=6], 
retinitis pigmentosa (RP) [n=6]) were tested on three Octopus 900 perimeters (Haag-
Streit AG, Köniz, Switzerland) with various maximum stimulus intensities (serial device 
104: 318 cd/m², 894: 1273 cd/m² and 1075: 3183 cd/m²). Grid 84NO (90° eccentricity, 
109 test locations) was applied for patients with RP, grid 30A (30° eccentricity, 83 test 
locations) for all other patients. Repeatability of the prototype version of GATE 
(GATEp) and agreement between GATEp and the commercially available EyeSuite 
version (GATEe) were assessed by comparing local differential luminance sensitivities 
(DLS) and median test durations by means of modified Bland-Altman plots. Mean 
sensitivities [MS] were compared.  
Results  
The comparison of DLS values showed very good repeatability for GATEp (bias <0.5 
dB, limits of agreement [LOA] <3 dB) and a very good to acceptable agreement 
between GATEp and GATEe (bias <2 dB, LOA <5 dB). Median examination durations 
for GATEp and GATEe were 7.8 min and 8.8 min for grid 30A, 6.7 min and 7.8 min for 
grid 84NO. MS values were comparable for both software versions, but higher values 
were assessed by the perimeter with the highest maximum stimulus luminance (serial 
device 1075). 
Conclusion 
The prototype version of GATE (GATEp) shows a very good repeatability. GATEp and 
the software version implemented in the EyeSuite software (GATEe) show good 
agreement regarding local differential luminance sensitivity and examination duration. 
GATEe can therefore be recommended for clinical practice.   
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5.1 Zusammenfassung  
Ziel  
Validierung der kommerziell erhältlichen „EyeSuite“-Version von GATE (German 
Adaptive Thresholding Estimation), eines neuen Algorithmus für schnelle 
Schwellenbestimmung in der automatischen statischen Perimetrie. 
Methoden 
30 Patienten mit Sehbahnläsionen unterschiedlicher Ursachen (anteriore ischämische 
Optikusneuropathie [n=3], Glaukom [n=15], (post-) chiasmale Sehbahnläsion [n=6], 
Retinitis pigmentosa (RP) [n=6]) wurden an drei Octopus 900 Perimetern (Haag-Streit 
AG, Köniz, Schweiz) mit verschiedenen maximalen Stimulusleuchtdichten (Seriengerät 
104: 318 cd/m², 894: 1273 cd/m² und 1075: 3183 cd/m²) untersucht. Raster 84NO (90° 
Exzentrizität, 109 Prüfpunkte) wurde für RP-Patienten angewandt, Raster 30A (30° 
Exzentrizität, 83 Prüfpunkte) für alle anderen. Die Reproduzierbarkeit der 
Prototypversion von GATE (GATEp) und die Übereinstimmung zwischen GATEp und 
der käuflich erwerbbaren EyeSuite-Version (GATEe) wurde bestimmt, indem lokale 
Lichtunterschiedlichkeitsempfindlichkeiten (LUE) und die mediane Untersuchungs-
dauer mit Hilfe modifizierter Bland-Altman-Diagramme verglichen wurden. Mean 
Sensitivity-(MS) Werte wurden verglichen.  
Ergebnisse 
Der Vergleich der LUE-Werte zeigte eine sehr gute Reproduzierbarkeit der Messungen 
für GATEp (Bias <0.5 dB, limits of agreement [LOA] <3 dB) und eine sehr gute bis 
akzeptable Übereinstimmung zwischen GATEp und GATEe (Bias <2 dB, LOA <5 dB). 
Die medianen Testzeiten betrugen für GATEp und GATEe 7.8 min und 8.8 min (Raster 
30A), 6.7 min und 7.8 min (Raster 84NO). Die MS-Werte waren für beide 
Softwareversionen vergleichbar, aber höher für das Gerät mit der größten maximalen 
Stimulusleuchtdichte (Seriengerät 1075). 
Fazit  
Die Prototypversion von GATE (GATEp) zeigt eine sehr gute Wiederholbarkeit.  
GATEp und die in EyeSuite implementierte Version, GATEe, zeigen in Bezug auf die 
LUE-Werte und Testzeiten eine gute Übereinstimmung. Daher kann GATEe für die 
klinische Praxis empfohlen werden.  
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10. Appendix 
Table 16: Elevated catch trial rates 
Catch trials Rate Patient ID Group of patients 
False-negative 31% 2205 Glaucoma 
False-negative 40% 2211 Glaucoma 
False-negative 33% 2212 Glaucoma 
False-negative 33% 2212 Glaucoma 
False-negative 36% 2216 (post-) chiasmal pathway lesions 
False-positive 33% 2216 (post-) chiasmal pathway lesions 
False-negative 40% 2217 Glaucoma 
False-negative 33% 2223 Glaucoma 
 
Table 17: Location IDs grid 30A 
Grid 30A 
Location ID X - Coordinate Y - Coordinate Eccentricity [°] Angle [°] 
0 0.0 0.0 0.0 0.0 
1 0.0 0.0 0.0 0.0 
2 1.4 1.4 2.0 45.0 
3 -1.4 1.4 2.0 135.0 
4 -1.4 -1.4 2.0 -135.0 
5 1.4 -1.4 2.0 -45.0 
6 5.8 1.6 6.0 15.4 
7 4.2 4.2 5.9 45.0 
8 -4.2 4.2 5.9 135.0 
9 -4.2 -4.2 5.9 -135.0 
10 4.2 -4.2 5.9 -45.0 
11 5.8 -1.6 6.0 -15.4 
12 2.0 5.8 6.1 71.0 
13 -2.0 5.8 6.1 109.0 
14 -5.8 2.0 6.1 161.0 
15 -5.8 -2.0 6.1 -161.0 
16 -2.0 -5.8 6.1 -109.0 
17 2.0 -5.8 6.1 -71.0 
18 2.0 9.7 9.9 78.3 
19 -2.0 9.7 9.9 101.7 
20 -9.7 2.0 9.9 168.3 
21 -9.7 -2.0 9.9 -168.3 
22 -2.0 -9.7 9.9 -101.7 
23 2.0 -9.7 9.9 -78.3 
24 9.7 2.6 10.0 15.0 
25 7.1 7.1 10.0 45.0 
26 7.1 7.1 10.0 45.0 
27 -7.1 7.1 10.0 135.0 
28 -7.1 7.1 10.0 135.0 
29 -7.1 -7.1 10.0 -135.0 
30 -7.1 -7.1 10.0 -135.0 
31 7.1 -7.1 10.0 -45.0 
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32 7.1 -7.1 10.0 -45.0 
33 9.7 -2.6 10.0 -15.0 
34 -10.8 6.2 12.5 150.1 
35 -10.8 -6.3 12.5 -149.7 
36 1.5 0.0 15.0 0.0 
37 13.0 7.5 15.0 30.0 
38 10.6 10.6 15.0 45.0 
39 3.9 14.5 15.0 74.9 
40 -3.9 14.5 15.0 105.1 
41 -10.6 10.6 15.0 135.0 
42 -10.6 -10.6 15.0 -135.0 
43 -3.9 -14.5 15.0 -105.1 
44 3.9 -14.5 15.0 -74.9 
45 10.6 -10.6 15.0 -45.0 
46 13.0 -7.5 15.0 -30.0 
47 17.4 1.5 17.5 4.9 
48 -15.2 8.7 17.5 150.2 
49 -17.4 2.0 17.5 173.4 
50 -17.4 -2.0 17.5 -173.4 
51 -15.2 -8.8 17.6 -149.9 
52 17.4 -1.5 17.5 -4.9 
53 5.2 19.3 20.0 74.9 
54 -5.2 19.3 20.0 105.1 
55 -5.2 -19.3 20.0 -105.1 
56 5.2 -19.3 20.0 -74.9 
57 19.3 -5.2 20.0 -15.1 
58 19.5 11.2 22.5 29.9 
59 11.3 19.5 22.5 59.9 
60 2.0 22.4 22.5 84.9 
61 -2.0 22.4 22.5 95.1 
62 -11.3 19.5 22.5 120.1 
63 -22.4 2.0 22.5 174.9 
64 -22.4 -2.0 22.5 -174.9 
65 -11.3 -19.5 22.5 -120.1 
66 -2.0 -22.4 22.5 -95.1 
67 2.0 -22.4 22.5 -84.9 
68 11.3 -19.5 22.5 -59.9 
69 19.5 -11.3 22.5 -30.1 
70 24.1 6.5 25.0 15.1 
71 17.7 17.7 25.0 45.0 
72 -17.7 17.7 25.0 135.0 
73 -24.1 6.5 25.0 164.9 
74 -24.1 -6.5 25.0 -164.9 
75 -17.7 -17.7 25.0 -135.0 
76 17.7 -17.7 25.0 -45.0 
77 24.1 -6.5 25.0 -15.1 
78 -23.8 13.7 27.5 150.1 
79 -23.8 -13.8 27.5 -149.9 
80 29.8 2.6 30.0 5.0 
81 25.9 15.0 30.0 30.0 
82 -29.9 2.0 30.0 176.2 
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83 -29.9 -2.0 30.0 -176.2 
84 -2.0 -29.9 30.0 -93.8 
85 2.0 -29.9 30.0 -86.2 
86 25.9 -15.0 30.0 -30.0 
87 29.9 -2.6 30.0 -5.0 
 
Table 18: Location IDs grid 84NO 
Grid 84NO 
Location ID X - Coordinate Y - Coordinate Eccentricity [°] Angle [°] 
0 0.0 0.0 0.0 0.0 
1 1.4 1.4 2.0 45.0 
2 -1.4 1.4 2.0 135.0 
3 -1.4 -1.4 2.0 -135.0 
4 1.4 -1.4 2.0 -45.0 
5 4.2 4.2 5.9 45.0 
6 -4.2 4.2 5.9 135.0 
7 -4.2 -4.2 5.9 -135.0 
8 4.2 -4.2 5.9 -45.0 
9 2.0 9.7 9.9 78.3 
10 -2.0 9.7 9.9 101.7 
11 -9.7 2.0 9.9 168.3 
12 -9.7 -2.0 9.9 -168.3 
13 -2.0 -9.7 9.9 -101.7 
14 2.0 -9.7 9.9 -78.3 
15 9.7 2.6 10.0 15.0 
16 7.1 7.1 10.0 45.0 
17 -7.1 7.1 10.0 135.0 
18 -7.1 -7.1 10.0 -135.0 
19 7.1 -7.1 10.0 -45.0 
20 9.7 -2.6 10.0 -15.0 
21 13.9 -1.2 14.0 -4.9 
22 15.0 0.0 15.0 0.0 
23 14.5 -3.9 15.0 -15.1 
24 15.9 -1.4 16.0 -5.0 
25 12.4 12.4 17.5 45.0 
26 -12.4 12.4 17.5 135.0 
27 -12.4 -12.4 17.5 -135.0 
28 12.4 -12.4 17.5 -45.0 
29 2.0 19.3 19.4 84.1 
30 -2.0 19.3 19.4 95.9 
31 -2.0 -19.3 19.4 -95.9 
32 2.0 -19.3 19.4 -84.1 
33 19.3 5.2 20.0 15.1 
34 -19.3 5.2 20.0 164.9 
35 -19.3 -5.2 20.0 -164.9 
36 19.3 -5.2 20.0 -15.1 
37 17.7 17.7 25.0 45.0 
38 -17.7 17.7 25.0 135.0 
39 -17.7 -17.7 25.0 -135.0 
40 17.7 -17.7 25.0 -45.0 
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41 29.8 2.6 30.0 5.0 
42 25.9   15.0 30.0 30.0 
43 15.0 25.9   30.0 60.0 
44 2.0 29.9 30.0 86.2 
45 -2.0 29.9 30.0 93.8 
46 -15.0 25.9 30.0 120.0 
47 -25.9 15.0 30.0 150.0 
48 -29.9 2.0 30.0 176.2 
49 -29.9 -2.0 30.0 -176.2 
50 -25.9 -15.0 30.0 -150.0 
51 -15.0 -25.9 30.0 -120.0 
52 -2.0 -29.9 30.0 -93.8 
53 2.0 -29.9 30.0 -86.2 
54 15.0 -25.9 30.0 -60.0 
55 25.9 -15.0 30.0 -30.0 
56 29.8 -2.6 30.0 -5.0 
57 -39.8 2.0 39.9 177.1 
58 -39.8 -2.0 39.9 -177.1 
59 39.8 3.5 40.0 5.0 
60 38.6 10.4 40.0 15.1 
61 28.3 28.3 40.0 45.0 
62 10.4 38.6 40.0 74.9 
63 -10.4 38.6 40.0 105.1 
64 -28.3 28.3 40.0 135.0 
65 -38.6 10.4 40.0 164.9 
66 -38.6 -10.4 40.0 -164.9 
67 -28.3 -28.3 40.0 -135.0 
68 -10.4 -38.6 40.0 -105.1 
69 10.4 -38.6 40.0 -74.9 
70 28.3 -28.3 40.0 -45.0 
71 38.6 -10.4 40.0 -15.1 
72 39.8 -3.5 40.0 -5.0 
73 2.0 49.8 49.8 87.7 
74 -2.0 49.8 49.8 92.3 
75 -49.8 2.0 49.8 177.7 
76 -49.8 -2.0 49.8 -177.7 
77 -2.0 -49.8 49.8 -92.3 
78 2.0 -49.8 49.8 -87.7 
79 49.8 4.4 50.0 5.0 
80 43.3 25.0 50.0 30.0 
81 25.0 43.3 50.0 60.0 
82 -25.0 43.3 50.0 120.0 
83 -43.3 25.0 50.0 150.0 
84 -43.3 -25.0 50.0 -150.0 
85 -25.0 -43.3 50.0 -120.0 
86 25.0 -43.3 50.0 -60.0 
87 43.3 -25.0 50.0 -30.0 
88 49.8 -4.4 50.0 -5.0 
89 58.0 15.5 50.0 15.0 
90 42.4 42.4 60.0 45.0 
91 -58.0 15.5 60.0 165.0 
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92 -58.0 -15.5 60,0 -165.0 
93 -15.5 -58.0 60,0 -105.0 
94 15.5 -58.0 60,0 -75.0 
95 42.4 -42.4 60,0 -45.0 
96 58.0 -15.5 60,0 -15.0 
97 -2.0 -64.8 64,8 -91.8 
98 2.0 -64.8 64,8 -88.2 
99 69.7 6.1 70,0 5.0 
100 60.6 35.0 70,0 30.0 
101 35.0 -60.6 70,0 -60.0 
102 60.6 -35.0 70,0 -30.0 
103 69.7 -6.1 70,0 -5.0 
104 77.3 20.7 80,0 15.0 
105 56.6 -56.6 80,0 -45.0 
106 77.3 -20.7 80,0 -15.0 
107 84.0 7.8 84,0 5.0 
108 84.0 -7.8 84,0 -5.0 
 
